Allen C. Ho, MD

RETINA

Allen C. Ho, MD, FACS

Co-Director Retina Service and Director, Retina Research
Wills Eye Hospital
Professor of Ophthalmology
Sidney Kimmel Medical College of Thomas Jefferson University

Research Interests: Allen C. Ho MD, FACS is Attending Surgeon and Director of Retina Research and Co-Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University. He maintains special interests in macular diseases, diabetic retinopathy, surgical retinal diseases and clinical trials investigating new treatments for vitreoretinal diseases including gene and cell therapies and new surgical drug delivery devices and techniques. His experience includes collaborative translational and clinical trial clinical research with expertise in study design, methodological testing, data analyses, surgical instrumentation and procedure development, execution and communication of these studies and their study results, and commercialization and patient access to care. He is past President of The Retina Society and a leader of Eyecelerator, the largest ophthalmic innovation meeting in the world.
He has deep experience in translational clinical research and been Study Chair, Steering Committee Member or Principal Investigator of over 70 clinical trials. Dr. Ho has served on the US FDA Ophthalmic Device Panel, AAO Innovation Task Force, AAO Ophthalmic Retina Technology Assessment Committee, AAO Retina Measures Group, AAO IRIS Registry Committee and is past Chair of the AAO Retina Subspecialty Days.
Dr. Ho has authored over 325 peer reviewed publications and several textbooks and is Editor-in-Chief of Current Opinion in Ophthalmology and Chief Medical Editor of Retina Today. He has received distinguished awards from the American Academy of Ophthalmology, multiple retina societies and the American Diabetes Association. He is a perennial awardee of national Castle Connolly awards and has been named to The Ophthalmologist Power 100 most influential eye specialists in the world on multiple occasions, most recently 2025.

2025 The Ophthalmologist 2025 Power List, 100 Most Influential Ophthalmologists in the World

2025 Castle Connelly 2025 Top Doctors in America

2025 Philadelphia Magazine 2025 Top Doctors

2024 The Ophthalmologist 2024 Power List, 100 Most Influential Ophthalmologists in the World

2024 Innovation Committee

2024 Philadelphia Magazine 2024 Top Doctors

2024 Castle Connelly 2024 Top Doctors in America

2024 Edmund Spaeth Lecture Orator

2023 Philadelphia Magazine, 2023 Top Doctors

2023 Castle Connelly 2023 Top Doctors in America

2023 The Ophthalmologist 2023 Power List, 100 Most Influential Ophthalmologists in the World

2023 Vit Buckle Society 2023 Lifetime Achievement Award

2023 Newsweek 2023 Top 100 US Ophthalmologists

2023 AAO IRIS Registry Committee

2023 AAO Society Leadership Board

2023 American Diabetes Association, Philadelphia Leadership Board

2023 Eyecelerator Innovation, Program Director

2023 Chief Medical Editor, Retina Toda

2022 Castle Connolly 2022, Top Doctors in America

2022 Philadelphia Magazine 2022 Top Doctors

2022 The Ophthalmologist 2022 Power list, 100 Most Influential Ophthalmologists in the World

2022 Retina Society, Immediate Past President

2022 Retina ALLIANCE Society Presidents (Retina, Macula and ASRS)

2022 AAO IRIS Registry Committee

2022 American Diabetes Associate, Philadelphia Leadership Board

2022 Eyecelerator Innovation, Program Director

2022 Editor in Chief, Current Opinion in Ophthalmology

2022 Chief Medical Editor, Retina Today

2021 Retina Society, President

2021 Retina ALLIANCE Society Presidents (Retina, Macula and ASRS)

2021 AAO IRIS Registry Committee

2021 AAO Society Leadership Board

2021 Diabetes Association, Philadelphia Leadership Board

2021 Editor in Chief, Current Opinion in Ophthalmology

2021 Chief Medical Editor, Retina Today

2020 The Ophthalmologist 2020 Power List, 100 Most influential Ophthalmologists in the World

2020 Castle Connelly 2020 Top Doctors in America

2020 Philadelphia Magazine 2020 Top Doctors

2019 Aspen Retinal Detachment Society Founders Award

2019 New England Ophthalmology Society Taylor Smith Medal

2018 American Academy of Ophthalmology Senior Honor Award

2018 Castle Connolly Top Doctors – America’s Top Ophthalmologist

2018 Philadelphia Magazine Top Ophthalmologist

2018 Power List 2018 – The Ophthalmologist – Top 100 most influential ophthalmologists in the world

2018 American Academy of Ophthalmology Secretariat Award

2015 American Diabetic Association 75th Anniversary Distinguished Physician Award

2012 ASRS Senior Honor Award

2011 ASRS Crystal Apple Award

1999 AAO Senior Achievement Award

1997 National Eye Institute Grant Awardee, Complications of Age-Related Macular Degeneration Prevention Trial Fundus Photograph Reading Center, Principal Investigator

1996 Macula Foundation, New York, NY, Grant Awardee; ocular angiogenesis

1995 Society of Heed Fellows

1995 McCabe Foundation, University of Pennsylvania, Grant Awardee; Animal models of ocular angiogenesis

1994 Heed Ophthalmic Foundation Research Fellowship

1993 ARVO / NEI Research Travel Fellowship Awardee

1988 Rudin Scholar in the Faculty of Medicine, Columbia University College of Physicians and Surgeons

1984 Phi Beta Kappa

1984 Phi Kappa Phi

1980 National Merit Scholar, Cornell University

Peer-Reviewed Original Publications
1. Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials. Ophthalmology. 2024 Jun;131(6):708-723.
2. Durrani AF, Momenaei B, Martin JL, Wakabayashi T, Hamdan SA, Gupta OP, Garg SJ, Khan MA, Mehta S, Vander J, Ho AC, Kuriyan AE; Secondary IOL Outcomes Study Group. Outcomes In Eyes With Retained Lens Fragments Undergoing Pars Plana Lensectomy And Scleral-Fixated Intraocular Lens Insertion. Retina. 2025 Feb 1;45(2):269-277.
3. Starr MR, Hinkle JC, Patel LG, Ammar MJ, Soares RR, Patel SN, Cohen MN, Hsu J, Yonekawa Y, Ho AC, Regillo CD, Gupta OP. Randomized Trial Comparing Microserrated Versus Conventional Internal Limiting Membrane Forceps For Internal Limiting Membrane Peeling. Retina. 2024 Aug 1;44(8):1323-1328.
4. Jacobson SG, Cideciyan AV, Ho AC, Peshenko IV, Garafalo AV, Roman AJ, Sumaroka A, Wu V, Krishnan AK, Sheplock R, Boye SL, Dizhoor AM, Boye SE. Erratum: Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations. iScience. 2024 Oct 28;27(11):111048.
5. Borkar D, Rahimy E, Khan MA, Ho AC, Hatfield M, Nguyen TH, Jones D, Fineman MS, McKeown A, Leng T, Baumal CR, Holekamp N. Functional Outcomes and Quality of Life in Geographic Atrophy in the Clinical Setting. Ophthalmol Retina. 2025 Mar;9(3):299-301.
6. Huang KY, Patel PA, Huang A, Ho AC, Jonas JB, Sun X, Chen Y, Zheng Y, Tham YC, Weng CY, Wong TY. Decline in US-China science: Can ophthalmology remain collaborative? Adv Ophthalmol Pract Res. 2024 Nov 6;5(1):13-15.
7. Yang P, Pardon LP, Ho AC, Lauer AK, Yoon D, Boye SE, Boye SL, Roman AJ, Wu V, Garafalo AV, Sumaroka A, Swider M, Viarbitskaya I, Aleman TS, Pennesi ME, Kay CN, Fujita KP, Cideciyan AV. Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study. Lancet. 2024 Sep 7;404(10456):962-970.
8. Momenaei B, Zhou A, Kazan AS, Wakabayashi T, Obeid A, Morano M, Khan MA, Xu D, Kuriyan AE, Yonekawa Y, Hsu J, Ho AC. Retinal Tear and Retinal Detachment Following Cataract Surgery in Eyes with a Previous History of Treated Phakic Retinal Tears. Ophthalmology. 2024 Jul 1:S0161-6420(24)00392-0.
9. Mandava NK, Kuriyan AE, Ho AC, Hsu J, Regillo CD, Klufas MA. Enhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema. Curr Opin Ophthalmol. 2024 May 1;35(3):197-204.
10. Campochiaro PA, Avery R, Brown DM, Heier JS, Ho AC, Huddleston SM, Jaffe GJ, Khanani AM, Pakola S, Pieramici DJ, Wykoff CC, Van Everen S. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study. Lancet. 2024 Apr 20;403(10436):1563-1573.
11. Durrani AF, Momenaei B, Wakabayashi T, Vemula S, Pandit SA, Hsu J, Ho AC, Spirn MJ, Klufas MA, Garg SJ, Vander JF, Regillo CD, Chiang A, Kuriyan AE, Yonekawa Y. Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema. Br J Ophthalmol. 2024 Feb 12: bjo-2023-324394.
12. Poh SSJ, Sia JT, Yip MYT, Tsai ASH, Lee SY, Tan GSW, Weng CY, Kadonosono K, Kim M, Yonekawa Y, Ho AC, Toth CA, Ting DSW. Artificial Intelligence, Digital Imaging, and Robotics Technologies for Surgical Vitreoretinal Diseases. Ophthalmol Retina. 2024 Jan 26:S2468-6530(24)00044-7.
13. Durrani A, Ho AC. Terson's Syndrome. N Engl J Med. 2023 Jun 22;388(25):e79. doi: 10.1056/NEJMicm2215931. Epub 2023 Jun 17
14. Soares RR, Sharpe J, Zhang Q, Ho AC, Yonekawa Y, Hsu J. Reply. Ophthalmology. 2024 Mar;131(3): e9-e10. doi: 10.1016/j.ophtha.2023.11.015. Epub 2023 Dec 20.
15. Awh KC, Mahmoudzadeh R, Salabati M, Mansour HA, Bechay J, Magagna J, Regillo CD, Ho AC, Garg SJ, Hsu J. Outcomes of Intentionally Suspending Treatment in Eyes With Advanced Neovascular Age-Related Macular Degeneration. American journal of ophthalmology. 2023 Dec 1; 256:20-6.
16. Rahimy E, Khan MA, Ho AC, Hatfield M, Nguyen TH, Jones D, McKeown A, Borkar D, Leng T, Ribeiro R, Holekamp N. Progression of Geographic Atrophy: Retrospective Analysis of Patients from the IRIS® Registry (Intelligent Research in Sight). Ophthalmology Science. 2023 Dec 1;3(4):100318.
17. Morano MJ, Khan MA, Zhang Q, Halfpenny CP, Wisner DM, Sharpe J, Li A, Tomaiuolo M, Haller JA, Hyman L, Ho AC. Incidence and Risk Factors for Retinal Detachment and Retinal Tear after Cataract Surgery: IRIS® Registry (Intelligent Research in Sight) Analysis. Ophthalmology Science. 2023 Dec 1;3(4):100314.
18. Contiliano JH, Meyer TE, Abbott DJ, Keane MF, Ho AC, Tsai MC, Khan IJ, inventors; Gyroscope Therapeutics Ltd, assignee. Therapeutic agent delivery device with convergent lumen. United States patent application US 18/196,806. 2023 Nov 9.
19. Mahmoudzadeh R, Williamson III JE, Salabati M, Soares RR, Gupta OP, Regillo CD, Ho AC, Hsu J. OCT-Based Description of Spontaneous Reattachment of Macula-Off Tractional Retinal Detachment With Significant Vision Improvement. Journal of VitreoRetinal Diseases. 2023 Nov 10:24741264231208254.
20. Salabati M, Massenzio E, Kim J, Awh K, Anderson H, Mahmoudzadeh R, Wakabayashi T, Hsu J, Garg S, Ho AC, Khan MA. Primary Retinal Detachment Repair in Eyes Deemed High Risk for Proliferative Vitreoretinopathy: Surgical Outcomes in 389 Eyes. Ophthalmology Retina. 2023 Nov 1;7(11):954-8.
21. Pandit SA, Momenaei B, Wakabayashi T, Mansour HA, Vemula S, Durrani AF, Pashaee B, Kazan AS, Ho AC, Klufas M, Regillo C. Real-World Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 2023 Oct 31.
22. Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators: [... Allen Chiang, Allen Ho, Allen Y Hu...]. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet. 2023 Oct 21;402(10411):1434-1448.
23. Cideciyan AV, Jacobson SG, Ho AC, Swider M, Sumaroka A, Roman AJ, Wu V, Russell RC, Viarbitskaya I, Garafalo AV, Schwartz MR. Durable vision improvement after a single intravitreal treatment with antisense oligonucleotide in CEP290-LCA: Replication in two eyes. American Journal of Ophthalmology Case Reports. 2023 Jun 20:101873.
24. Israilevich RN, Syed ZA, Xu D, Kaiser RS, Garg SJ, Spirn MJ, Mehta S, Gupta OP, Ho AC, Kuriyan AE, Yonekawa Y. Neurotrophic keratopathy following rhegmatogenous retinal detachment surgery. Canadian Journal of Ophthalmology. 2023 Jun 14.
25. Kay CN, Yang P, Cideciyan AV, Ho A, Lauer AK, Boye SE, Boye SL, Roman AJ, Wu V, Garafalo AV, Sumaroka A. Six-month safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D (LCA1). Investigative Ophthalmology & Visual Science. 2023 Jun 1;64(8):1914.
26. Munk MR, Gonzalez VH, Boyer DS, Do DV, Xavier S, Hu A, Rosen RB, Lad E, Schneiderman T, Ho AC, Jaffe G. LIGHTSITE III (Interim Analysis): Evaluation of Multiwavelength Photobiomodulation in Dry Age-Related Macular Degeneration Using the LumiThera Valeda Light Delivery System. Investigative Ophthalmology & Visual Science. 2022 Jun 1;63(7):379-F0210.
27. Wakabayashi T, Patel N, Bough M, Nahar A, Sheng Y, Momenaei B, Salabati M, Mahmoudzadeh R, Kuriyan AE, Spirn MJ, Chiang A, Hsu J, Fineman MS, Regillo CD, Sivalingam A, Ho AC, Gupta OP, Yonekawa Y. Vitrectomy for Vitreous Hemorrhage Associated with Retinal Vein Occlusion: Visual Outcomes, Prognostic Factors, and Sequelae. RETINA. 2022 May 12:10-97.
28. Allen C Ho, Eyal Banin, Adiel Barak, David S Boyer, Rita Ehrlich, Tareq Jaouni, H Richard MacDonald, Christopher D Riemann, David Telander, Jordi Mones, Avi Ben Shabat, Gary S Hogge, Benjamin Reubinoff; Safety and Efficacy of a Phase 1/2a Clinical Trial of Transplanted Allogeneic Retinal Pigmented Epithelium (RPE, OpRegen) Cells in Advanced Dry Age-Related Macular Degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2022;63(7):1862.
29. Sunir Garg, Charles Clifton Wykoff, Nathan Steinle, Giovanni Staurenghi, Debra Morris, Allen Chiang, Caleb Bliss, Daniel Jones, Ramiro Ribeiro, Allen C Ho, Jeffrey S Heier; Impact of baseline imbalances on the efficacy of pegcetacoplan for the treatment of geographic atrophy (GA): A post hoc analysis of OAKS, DERBY, and FILLY. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1501.
30. Kymes SM, Oden NL, VanVeldhuisen PC, Scott IU, Ip MS, Blodi BA, King J; SCORE2 Investigator Group: [… Allen Chiang, Allen Ho, Jason Hsu…]. Cost-Utility Comparison of Bevacizumab and Aflibercept in the Treatment of Central or Hemiretinal Vein Occlusion in the SCORE2 Trial. JAMA Ophthalmol. 2023 May 11: e231463.
31. Levin HJ, Mehta MS, Storey PP, Patel SN, Kuley B, Wibbelsman TD, Obeid A, Garg S, Vander J, Dunn JP, Ho AC. Endophthalmitis following cataract surgery: visual outcomes, microbial spectrum and complications. Curr Opin Ophthalmol. 2023 May 1;34(3):237-242.
32. Pandit S, Ho AC, Yonekawa Y. Recent advances in the management of proliferative diabetic retinopathy. Curr Opin Ophthalmol. 2023 May 1;34(3):232-236.
33. Soares RR, Mokhashi N, Sharpe J, Zhang Q, Hinkle J, Patel SN, Ho AC, Yonekawa Y, Hsu J. Patient Accessibility to Eye Care in the United States. Ophthalmology. 2023 Apr;130(4):354-360.
34. Wai KM, Saroj N, Boucher N, Aggarwal N, Ho AC, Rahimy E. Evaluating the Effect of Hypoglycemic Agents on Diabetic Retinopathy Progression. Ophthalmic Surg Lasers Imaging Retina. 2023 Mar;54(3):158-165.
35. Huang D, Starr MR, Kaiser RS, Mehta S, Park CH, Khan MA, Gupta OP, Kuriyan AE, Yonekawa Y, Ho AC, Garg SJ, Cohen MN, Hsu J. Reply. Retina. 2023 Mar 1;43(3): e16-e17.
36. Torjani A, Mahmoudzadeh R, Salabati M, Cai L, Hsu J, Garg S, Ho AC, Yonekawa Y, Kuriyan AE, Starr MR. Factors Associated with Fluctuations in Central Subfield Thickness in Patients with Diabetic Macular Edema Using Diabetic Retinopathy Clinical Research Protocols T and V. Ophthalmol Sci. 2022 Sep 23;3(1):100226.
37. Xue K, Hua P, Maguire MG, Daniel E, Jaffe GJ, Grunwald JE, Ying GS; Comparison of age-related macular degeneration Treatments Trials (CATT) Research Group: […Richard Kaiser, Gary Brown, Allen Ho, Jason Hsu, James Vander…]. Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmol Retina. 2023 Feb 19: S2468-6530(23)00073-8.
38. Shah SM, Eliott D, Cox JT, Yonekawa Y, Mahmoudzadeh R, Peck TJ, Regillo CD, Ho AC, Oellers P, Choudhury M, Arboleda N, Gentile RC, Sun V, Iezzi R. EPIRETINAL MEMBRANE WITH FOVEAL HERNIATION: Visual and Surgical Outcomes. Retina. 2023 Feb 1;43(2):182-190.
39. Ho AC, Schechet SA, Mathai M, Reddy S, Elman MJ, Garfinkel RA, Ladd B, Wagner AL, Sanborn GE, Jacobs JH, Busquets MA, Chew EY. The Predictive Value of False-Positive Foresee Home Alerts in the ALOFT Study. Ophthalmol Retina. 2023 Feb;7(2):196-198.
40. Heier JS, Ho AC, Boyer DS, Csaky K, Vitti R, Perlee L, Chu KW, Asmus F, Leal S, Zeitz O, Cheng Y, Schmelter T, Brown DM. Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial. J Vitreoretin Dis. 2022 Dec 30;7(1):8-15.
41. Starr MR, Xu D, Soares RR, Boucher N, Chiang A, Cohen MN, Ho AC, Klufas MA, Khan MA, Mehta S, Yonekawa Y, Kuriyan AE. Trends in Utilization of Vitreoretinal Services Following the Initial Phase of the 2020 COVID-19 Pandemic. Ophthalmic Surg Lasers Imaging Retina. 2023 Jan;54(1):15-23.
42. Salabati M, Mahmoudzadeh R, Starr MR, Zhang Q, Sharpe J, Hsu J, Ho AC, Regillo C, Kuriyan AE. REFRACTIVE ERROR CHANGE DURING TREATMENT OF DIABETIC MACULAR EDEMA: A Post Hoc Analysis of the Diabetic Retinopathy Clinical Research Protocol T Trial. Retina. 2022 Nov 1;42(11):2059-2065.
43. Starr MR, Huang D, Wong JC, Patel LG, Ammar M, Hsu J, Sivalingam A, Mehta S, Ho AC, Kuriyan AE, Khan MA, Cohen MN, Xu D, Lee D, Moster MR, Yonekawa Y. Prevalence, characteristics, and outcomes of rhegmatogenous retinal detachment in eyes with trabeculectomy or glaucoma drainage devices. Retina. 2022 Nov 1;42(11):2039-2045.
44. Jacobson SG, Cideciyan AV, Ho AC, Roman AJ, Wu V, Garafalo AV, Sumaroka A, Krishnan AK, Swider M, Mascio AA, Kay CN, Yoon D, Fujita KP, Boye SL, Peshenko IV, Dizhoor AM, Boye SE. Night vision restored in days after decades of congenital blindness. iScience. 2022 Oct 4;25(10):105274.
45. Wakabayashi T, Mahmoudzadeh R, Salabati M, Garg SJ, Ho AC, Spirn MJ. Utility of Removal of Vitreous Cortex Remnants during Vitrectomy for Primary Rhegmatogenous Retinal Detachment Repair. Curr Eye Res. 2022 Oct;47(10):1444-1449.
46. Core JQ, Pistilli M, Hua P, Daniel E, Grunwald JE, Toth CA, Jaffe GJ, Martin DF, Maguire MG, Ying GS; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group: […Sunir Garg, Allen Ho, Jason Hsu, Carl Regillo, James Vander…]. Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmol Retina. 2022 Sep;6(9):771-785.
47. Meghpara BB, Lee JK, Rapuano CJ, Mian SI, Ho AC. Pilocarpine 1.25% and the changing landscape of presbyopia treatment. Curr Opin Ophthalmol. 2022 Jul 1;33(4):269-274.
48. Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group: [...Allen Chiang, Mitchell Fineman, Omesh Gupta, Allen Ho, Samuel Houston, Jason Hsu...]. Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18. JAMA Ophthalmol. 2022 May 1;140(5):458-464.
49. Core JQ, Hua P, Daniel E, Grunwald JE, Jaffe G, Maguire MG, Ying GS; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group: […Mitchell Fineman, Michele Formoso, Sunir Garg, Lisa Grande, Carolyn Herbert, Allen Ho, Jason Hsu…]. Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials. Br J Ophthalmol. 2022 Apr 15: bjophthalmol-2021-320665.
50. Cecilia S. Lee; Marian Blazes; Alice Lorch; Suzann Pershing; Leslie Hyman; Allen C. Ho; Julia Haller; Joan W. Miller; Emily Y. Chew; Flora Lum; Aaron Y. Lee. American Academy of Ophthalmology Intelligent Research in Sight (IRIS®) Registry and the IRIS Registry Analytic Center Consortium. Ophthalmology Science. 2022 March.
51. Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, YOSEMITE and RHINE Investigators: [... Patrick Higgins, Akito Hirakata, Allen Ho, Nancy Holekamp, Shigeru Honda, Jason Hsu...]. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. The Lancet. 2022 Jan 24.
52. Cideciyan AV, Jacobson SG, Ho AC, Krishnan AK, Roman AJ, Garafalo AV, Wu V, Swider M, Sumaroka A, Van Cauwenbergh C, Russell SR. Restoration of Cone Sensitivity to Individuals with Congenital Photoreceptor Blindness within the Phase 1/2 Sepofarsen Trial. Ophthalmology Science. 2022 Jun 1;2(2):100133.
53. Russell SR, Drack AV, Cideciyan AV, Jacobson SG, Leroy BP, Van Cauwenbergh C, Ho AC, Dumitrescu AV, Han IC, Martin M, Pfeifer WL, Sohn EH, Walshire J, Garafalo AV, Krishnan AK, Powers CA, Sumaroka A, Roman AJ, Vanhonsebrouck E, Jones E, Nerinckx F, De Zaeytijd J, Collin RWJ, Hoyng C, Adamson P, Cheetham ME, Schwartz MR, den Hollander W, Asmus F, Platenburg G, Rodman D, Girach A. Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b/2 trial. Nat Med. 2022 Apr 4. doi: 10.1038/s41591-022-01755-w. Epub ahead of print. PMID: 35379979.
54. Light JG, Pyfer MS, Salabati M, Mahmoudzadeh R, Wakabayashi T, Ho AC. Stellate nonhereditary idiopathic foveomacular retinoschisis and an approach to the differential diagnosis of macular star. Curr Opin Ophthalmol. 2022 Mar 2. doi: 10.1097/ICU.0000000000000844. Epub ahead of print. PMID: 35239516.
55. Huang D, Starr MR, Patel LG, Ammar M, Kaiser RS, Mehta S, Park C, Khan MA, Gupta O, Kuriyan AE, Yonekawa Y, Ho AC, Garg S, Cohen MN, Hsu J. Factors affecting retinal re-detachment following silicone oil removal for rhegmatogenous retinal detachments. Retina. 2022 Feb 4. doi: 10.1097/IAE.0000000000003445. Epub ahead of print. PMID: 35174811.
56. Mahmoudzadeh R, Israilevich R, Salabati M, Hsu J, Garg SJ, Regillo CD, Ho AC, Khan MA. Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane: Optical Coherence Tomography Biomarkers of Visual Outcomes in 322 Eyes. Ophthalmol Retina. 2021 Oct 27: S2468-6530(21)00335-3. doi: 10.1016/j.oret.2021.10.008. Epub ahead of print. PMID: 34718218.
57. Salabati M, Mahmoudzadeh R, Wakabayashi T, Hinkle JW, Ho AC. Indications for surgical management of retained lens fragments. Curr Opin Ophthalmol. 2021 Nov 5. doi: 10.1097/ICU.0000000000000823. Epub ahead of print. PMID: 34743089.
58. Shields CN, Cherkas EG, Mokhashi N, Cai LZ, Pandit RR, Patel SN, Hsu J, Kuriyan AE, Klufas MA, Ho AC. Barriers to Follow-Up Retinal Care During the COVID-19 Pandemic: A Survey Study. Ophthalmic Surg Lasers Imaging Retina. 2021 Oct;52(10):526-533. doi: 10.3928/23258160-20210904-01. Epub 2021 Oct 1. PMID: 34661462.
59. Fromal OV, Swaminathan V, Soares RR, Ho AC. Recent advances in diagnosis and management of sympathetic ophthalmia. Curr Opin Ophthalmol. 2021 Nov 1;32(6):555-560. doi: 10.1097/ICU.0000000000000803. PMID: 34494974.
60. Starr MR, Ammar MJ, Patel LG, Boucher N, Yonekawa Y, Garg SJ, Hsu J, Ho AC, Regillo CD, Chiang A. Comparative Incidence of Postoperative Hemorrhage in Vitreoretinal Surgery in Patients on Anti-Coagulants. Ophthalmic Surg Lasers Imaging Retina. 2021 Jul;52(7):374-379. doi: 10.3928/23258160-20210628-03. Epub 2021 Jul 1. PMID: 34309424.
61. Jain N, Liao A, Garg SJ, Patel SN, Wykoff CC, Yu HJ, London NJS, Khurana RN, Zacks DN; Macula Society Pentosan Polysulfate Maculopathy Study Group: […Allen Chiang, James P Dunn, Mitchell S Fineman, David H Fischer, Sunir J Garg, Omesh P Gupta, Allen C Ho, Jason Hsu, Thomas L Jenkins, Richard S Kaiser, Carl H Park, Samir N Patel, Arunan Sivalingam, Marc J Spirn, James F Vander, Yoshihiro Yonekawa...]. Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study. Ophthalmol Retina. 2022 Mar;6(3):219-227. doi: 10.1016/j.oret.2021.07.004. Epub 2021 Jul 21. PMID: 34298229.
62. Matsunaga DR, Salabati M, Obeid A, Wibbelsman TD, Wu C, Mahmoudzadeh R, Ojalvo I, Bilello J, Sivalingam A, Ho AC, Chiang A, Hsu J. Outcomes of Eyes With Diabetic Macular Edema That Are Lost to Follow-up After Anti-Vascular Endothelial Growth Factor Therapy. Am J Ophthalmol. 2021 Jul 17; 233:1-7. doi: 10.1016/j.ajo.2021.06.028. Epub ahead of print. PMID: 34283979.
63. Starr MR, Salabati M, Mahmoudzadeh R, Patel LG, Ammar MJ, Hsu J, Garg S, Ho AC, Kuriyan AE. Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting. Am J Ophthalmol. 2021 Dec; 232:90-97. doi: 10.1016/j.ajo.2021.06.030. Epub 2021 Jul 17. PMID: 34283986.
64. Khan MA, Sridhar J, Kuriyan AE, Ho AC. Private Equity Transactions: Perceptions of U.S. Vitreoretinal Surgery Fellows. Ophthalmol Retina. 2021 Aug;5(8):832-834. doi: 10.1016/j.oret.2020.12.014. Epub 2021 Feb 23. PMID: 33359546.
65. Salabati M, Mahmoudzadeh R, Wong JC, Patel D, Patel SN, Obeid A, Sivalingam A, Vander JF, Garg SJ, Ho AC, Regillo CD, Hsu J. Outcomes of eyes with retinal vein occlusion that are lost to follow-up after antivascular endothelial growth factor therapy. Br J Ophthalmol. 2021 Jun 28: bjophthalmol-2021-319180. doi: 10.1136/bjophthalmol-2021-319180. Epub ahead of print. PMID: 34183325.
66. Starr MR, Xu D, Boucher N, Saroj N, Patel LG, Ammar M, Pandit RR, Jenkins TL, Ho AC. Characterizing Progression to Neovascular AMD in Fellow Eyes of Patients Treated With Intravitreal Anti-VEGF Injections. Ophthalmic Surg Lasers Imaging Retina. 2021 Mar;52(3):123-128. doi: 10.3928/23258160-20210302-02. Epub 2021 Mar 1. PMID: 34038686.
67. Iovino C, Au A, Chhablani J, Parameswarappa DC, Rasheed MA, Cennamo G, Cennamo G, Montorio D, Ho AC, Xu D, Querques G, Borrelli E, Sacconi R, Pichi F, Woodstock E, Sadda SR, Corradetti G, Boon CJF, van Dijk EHC, Loewenstein A, Zur D, Yoshimi S, Freund KB, Peiretti E, Sarraf D. Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study. Am J Ophthalmol. 2020 Sep; 217:104-113. doi: 10.1016/j.ajo.2020.04.022. Epub 2020 Apr 28. PMID: 32360342.
68. Hsu J, Patel SN, Wolfe JD, Shah CP, Chen E, Jenkins TL, Wibbelsman TD, Obeid A, Mikhail M, Garg SJ, Ho AC, Chiang A, Spirn MJ, Vander JF. Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial. JAMA Ophthalmol. 2020 May 1;138(5):560-567. doi: 10.1001/jamaophthalmol.2020.0724. PMID: 32239190; PMCID: PMC7118620.
69. Charles S, Ho AC, Dugel PU, Riemann CD, Berrocal MH, Gupta S, Hamilton C, Abulon DJK. Clinical comparison of 27-gauge and 23-gauge instruments on the outcomes of pars plana vitrectomy surgery for the treatment of vitreoretinal diseases. Curr Opin Ophthalmol. 2020 May;31(3):185-191. doi: 10.1097/ICU.0000000000000659. PMID: 32235251.
70. Ammar MJ, Hsu J, Chiang A, Ho AC, Regillo CD. Age-related macular degeneration therapy: a review. Curr Opin Ophthalmol. 2020 May;31(3):215-221. doi: 10.1097/ICU.0000000000000657. PMID: 32205470.
71. Heier JS, Ho AC, Samuel MA, Chang T, Riemann CD, Kitchens JW, Slakter JS, Leiderman YI, Spencer R, Williams GA, Hickson-Curran SB, Keane M, Baldassarre JS; Prelude Study Group. Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study. Ophthalmol Retina. 2020 Apr;4(4):384-393. doi: 10.1016/j.oret.2019.11.011. Epub 2019 Nov 19. PMID: 32033908.
72. Ali F, Kasi S, Saroj N, Baker K, Thompson D, Vitti R, Berliner AJ, Metzig C, Ho AC. Impact of Posterior Vitreous Detachment on Treatment Outcomes in Diabetic Macular Edema. Ophthalmol Retina. 2020 Apr;4(4):452-454. doi: 10.1016/j.oret.2019.12.002. Epub 2019 Dec 9. PMID: 31982388.
73. Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga PE, da Cruz L, Walter P, Augustin AJ, Chizzolini M, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R Jr, Gaucher D, Arevalo JF, Gregori NZ, Grisanti S, Özmert E, Yoon YH, Kokame GT, Lim JI, Szurman P, de Juan E Jr, Rezende FA, Salzmann J, Richard G, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS. Adverse Events Of The Argus Ii Retinal Prosthesis: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion. Retina. 2020 Feb;40(2):303-311. doi: 10.1097/IAE.0000000000002394. PMID: 31972801.
74. Patel SN, Wu C, Obeid A, Sivalingam M, Gervasio K, Wibbelsman TD, Levin H, Xu D, Regillo CD, Hsu J, Ho AC. Sociodemographic Factors in Neovascular Age-Related Macular Degeneration. Ophthalmology. 2020 Feb;127(2):280-282. doi: 10.1016/j.ophtha.2019.09.038. Epub 2019 Oct 4. PMID: 31785890.
75. Ho AC, Wibbelsman TD, Pandit RR, Xu D. Trends in Ophthalmic Imaging: Implications and Outlook. Am J Ophthalmol. 2020 Feb; 210:1-2. doi: 10.1016/j.ajo.2019.10.008. Epub 2019 Nov 26. PMID: 31780042.
76. Soares RR, Mellen P, Garrigan H, Obeid A, Wibbelsman TD, Borkar D, Ho AC, Hsu J. Outcomes of Eyes Lost to Follow-up with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmol Retina. 2020 Feb;4(2):134-140. doi: 10.1016/j.oret.2019.07.010. Epub 2019 Jul 24. PMID: 31540854.
77. Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga P, da Cruz L, Walter P, Augustin AJ, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R, Gaucher D, Arevalo JF, Gregori NZ, Wiedemann P, Özmert E, Lim JI, Rezende FA, Huang SS, Merlini F, Patel U, Greenberg RJ, Justus S, Bacherini D, Cinelli L, Humayun MS. Hypotony and the Argus II retinal prosthesis: causes, prevention and management. Br J Ophthalmol. 2020 Apr;104(4):518-523. doi: 10.1136/bjophthalmol-2019-314135. Epub 2019 Jul 12. PMID: 31300454.
78. Adam MK, Shahlaee A, Samara WA, Maguire JI, Ho AC, Hsu J. En Face Versus 12-Line Radial Optical Coherence Tomography Scan Patterns For Detection Of Macular Fluid In Neovascular Age-Related Macular Degeneration. Retin Cases Brief Rep. 2020 Winter;14(1):53-60. doi: 10.1097/ICB.0000000000000616. PMID: 28816861.
79. Patel SN, Storey PP, Levin H, Pancholy M, Obeid A, Wibbelsman TD, Kuley B, Ho AC, Hsu J, Garg SJ, Vander JF, Dunn JP. Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic Cultures. Ophthalmol Retina. 2021 Jan;5(1):16-22. doi: 10.1016/j.oret.2020.06.028. Epub 2020 Jun 26. PMID: 32599176.
80. Matsunaga DR, Su D, Sioufi K, Obeid A, Wibbelsman T, Ho AC, Regillo CD. The Timing of Large Submacular Hemorrhage Secondary to Age-Related Macular Degeneration Relative to Anti-VEGF Therapy. Ophthalmol Retina. 2021 Apr;5(4):342-347. doi: 10.1016/j.oret.2020.07.028. Epub 2020 Aug 4. PMID: 32763426.
81. Xu D, Uhr J, Patel SN, Pandit RR, Jenkins TL, Khan MA, Ho AC. Sociodemographic Factors Influencing Rhegmatogenous Retinal Detachment Presentation and Outcome. Ophthalmol Retina. 2021 Apr;5(4):337-341. doi: 10.1016/j.oret.2020.08.001. Epub 2020 Aug 6. PMID: 32771613.
82. Chiang A, Garg SJ, Klufas MA, Ho AC, Hill L, Tsuboi M, Stoilov I. Ultra-Response to Ranibizumab: Improvement by 4 or More Steps in Diabetic Retinopathy Severity in Diabetic Retinopathy Clinical Research Network Protocol S. Ophthalmol Retina. 2021 Mar;5(3):251-260. doi: 10.1016/j.oret.2020.07.009. Epub 2020 Jul 29. PMID: 32735903.
83. Bakshi SK, Ho AC, Chodosh J, Fung AT, Chan RVP, Ting DSW. Training in the year of the eye: the impact of the COVID-19 pandemic on ophthalmic education. Br J Ophthalmol. 2020 Sep;104(9):1181-1183. doi: 10.1136/bjophthalmol-2020-316991. Epub 2020 Jun 25. PMID: 32586935; PMCID: PMC7577089.
84. Pandit RR, Wibbelsman TD, Considine SP, Jenkins TL, Xu D, Levin HJ, Obeid A, Ho AC. Distribution and Practice Patterns of Retina Providers in the United States. Ophthalmology. 2020 Nov;127(11):1580-1581. doi: 10.1016/j.ophtha.2020.04.016. Epub 2020 Apr 20. PMID: 32473740.
85. Wu C, Patel SN, Jenkins TL, Obeid A, Ho AC, Yonekawa Y. Ocular trauma during COVID-19 stay-at-home orders: a comparative cohort study. Curr Opin Ophthalmol. 2020 Sep;31(5):423-426. doi: 10.1097/ICU.0000000000000687. PMID: 32740065.
86. Patel SN, Hsu J, Sivalingam MD, Chiang A, Kaiser RS, Mehta S, Park CH, Regillo CD, Sivalingam A, Vander JF, Ho AC, Garg SJ; Wills Post-Injection Endophthalmitis (PIE) Study Group. The Impact of Physician Face Mask Use on Endophthalmitis After Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2021 Feb; 222:194-201. doi: 10.1016/j.ajo.2020.08.013. Epub 2020 Sep 2. PMID: 32888902; PMCID: PMC7462768.
87. Starr MR, Patel LG, Ho AC. Presumed Sickle Cell Retinopathy in an Elderly Woman. JAMA Ophthalmol. 2020 Nov 1;138(11):1205-1206. doi: 10.1001/jamaophthalmol.2020.1614. PMID: 32880600.
88. Xu D, Levin HJ, Garrigan H, Wibbelsman TD, Obeid A, Pandit RR, Jenkins TL, Mehta S, Ho AC, Hsu J, Regillo CD. Outcomes and Complications of In-Office Laser Demarcation of Peripheral Rhegmatogenous Retinal Detachments. Ophthalmic Surg Lasers Imaging Retina. 2020 Aug 1;51(8):428-434. doi: 10.3928/23258160-20200804-02. PMID: 32818274.
89. Patel SN, Mahmoudzadeh R, Salabati M, Soares RR, Hinkle J, Hsu J, Garg SJ, Regillo CD, Ho AC, Cohen MN, Khan MA, Yonekawa Y, Chiang A, Gupta OP, Kuriyan AE. Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections. Am J Ophthalmol. 2021 Mar; 223:178-183. doi: 10.1016/j.ajo.2020.10.017. Epub 2020 Oct 28. PMID: 33129809; PMCID: PMC7598764.
90. Patel LG, Peck T, Starr MR, Ammar MJ, Khan MA, Yonekawa Y, Klufas MA, Regillo CD, Ho AC, Xu D. Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic: A Historical Cohort Study. Ophthalmology. 2021 May;128(5):686-692. doi: 10.1016/j.ophtha.2020.10.009. Epub 2020 Oct 13. PMID: 33058938; PMCID: PMC7550253.
91. Vingopoulos F, Nair A, See CW, Iyengar N, Haberman I, Sperber L, Lazzaro DR, Singh R, Ho A, Gupta O, Sharma S, Modi Y. Position Of In-The-Bag Posterior Chamber Intraocular Lenses Relative To The Limbus: Applications to Scleral-Sutured Lenses. Retina. 2021 Jul 1;41(7):1533-1540. doi: 10.1097/IAE.0000000000003044. PMID: 33239547.
92. Khan MA, Sridhar J, Kuriyan AE, Ho AC. Private Equity Transactions: Perceptions of U.S. Vitreoretinal Surgery Fellows. Ophthalmol Retina. 2021 Aug;5(8):832-834. doi: 10.1016/j.oret.2020.12.014. Epub 2021 Feb 23. PMID: 33359546.
93. Mellen PL, Obeid A, Wibbelsman TD, Hsu J, Konkoly MA, Velez MR, Calem DB, Sioufi K, Jenkins TL, Xu D, Chiang A, Gupta OP, Spirn M, Regillo CD, Ho AC, Klufas MA. Clinical Outcomes of Eyes With Diabetic Macular Edema Switched From Aflibercept to Ranibizumab Therapy. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 1;51(12):691-697. doi: 10.3928/23258160-20201202-03. PMID: 33339050.
94. Pancholy M, Storey PP, Levin HJ, Obeid A, Patel SN, Kuley B, Hsu J, Spirn MJ, Fineman M, Klufas MA, Gupta O, Ho AC, Garg SJ. Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year Period. Curr Eye Res. 2021 Sep;46(9):1370-1377. doi: 10.1080/02713683.2021.1874023. Epub 2021 Jan 31. PMID: 33522314.
95. Peck TJ, Patel SN, Ho AC. Endophthalmitis after cataract surgery: an update on recent advances. Curr Opin Ophthalmol. 2021 Jan;32(1):62-68. doi: 10.1097/ICU.0000000000000727. PMID: 33196543.
96. Xu D, Khan MA, Ho AC. Creating an Ocular Biofactory: Surgical Approaches in Gene Therapy for Acquired Retinal Diseases. Asia Pac J Ophthalmol (Phila). 2021 Jan 4;10(1):5-11. doi: 10.1097/APO.0000000000000362. PMID: 33399391.
97. Soares RR, Gopal AD, Parikh D, Shields CN, Patel S, Hinkle J, Sharpe J, Ho AC, Regillo CD, Haller J, Yonekawa Y. Geographic Access Disparities of Clinical Trials in Neovascular Age-Related Macular Degeneration in the United States. Am J Ophthalmol. 2021 Sep;229:160-168. doi: 10.1016/j.ajo.2021.04.001. Epub 2021 Apr 20. PMID: 33848533.
98. Ho AC, Heier JS, Holekamp NM, Garfinkel RA, Ladd B, Awh CC, Singh RP, Sanborn GE, Jacobs JH, Elman MJ, Loewenstein A, Eichenbaum DA. Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration. J Clin Med. 2021 Mar 25;10(7):1355. doi: 10.3390/jcm10071355. PMID: 33806058; PMCID: PMC8036735.
99. Cideciyan AV, Jacobson SG, Ho AC, Garafalo AV, Roman AJ, Sumaroka A, Krishnan AK, Swider M, Schwartz MR, Girach A. Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: a case report. Nat Med. 2021 May;27(5):785-789. doi: 10.1038/s41591-021-01297-7. Epub 2021 Apr 1. PMID: 33795869; PMCID: PMC8127404.
100. Obeid A, Hsu J, Ehmann D, Gao X, Sridhar J, Chiang A, Park CH, Ho AC. Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor For Retinal Vein Occlusion: A Pilot Study. Retin Cases Brief Rep. 2021 Mar 1;15(2):120-126. doi: 10.1097/ICB.0000000000000752. PMID: 29864044.
101. Jacobson SG, Cideciyan AV, Ho AC, Peshenko IV, Garafalo AV, Roman AJ, Sumaroka A, Wu V, Krishnan AK, Sheplock R, Boye SL, Dizhoor AM, Boye SE. Safety and improved efficacy signals following gene therapy in childhood blindness caused by GUCY2D mutations. iScience. 2021 Apr 11;24(5):102409. doi: 10.1016/j.isci.2021.102409. PMID: 33997691; PMCID: PMC8099775.
102. Jenkins TL, Aderman CM, Ho AC. Reversible Retinal Toxicity In A Patient Taking Axitinib. Retin Cases Brief Rep. 2021 May 1;15(3):239-242. doi: 10.1097/ICB.0000000000000771. PMID: 30015771.
103. Starr MR, Israilevich R, Zhitnitsky M, Cheng QE, Soares RR, Patel LG, Ammar MJ, Khan MA, Yonekawa Y, Ho AC, Cohen MN, Sridhar J, Kuriyan AE. Practice Patterns and Responsiveness to Simulated Common Ocular Complaints Among US Ophthalmology Centers During the COVID-19 Pandemic. JAMA Ophthalmol. 2020 Sep 1;138(9):981-988. doi: 10.1001/jamaophthalmol.2020.3237. PMID: 32777008; PMCID: PMC7407319.
104. Wu C, Patel SN, Jenkins TL, Obeid A, Ho AC, Yonekawa Y. Ocular trauma during COVID-19 stay-at-home orders: a comparative cohort study. Current Opinion in Ophthalmology. 2020 Sep 1;31(5):423-6. doi: 10.1097/ICU.0000000000000687
105. Bakshi SK, Ho AC, Chodosh J, Fung AT, Chan RP, Ting DS. Training in the year of the eye: the impact of the COVID-19 pandemic on ophthalmic education. doi: 10.1136/bjophthalmol-2020-316991
106. Xu D, Levin HJ, Garrigan H, Wibbelsman TD, Obeid A, Pandit RR, Jenkins TL, Mehta S, Ho AC, Hsu J, Regillo CD. Outcomes and Complications of In-Office Laser Demarcation of Peripheral Rhegmatogenous Retinal Detachments. Ophthalmic Surgery, Lasers and Imaging Retina. 2020 Aug 25;51(8):428-34. doi: 10.3928/23258160-20200804-02
107. Xu D, Uhr J, Patel SN, Pandit RR, Jenkins TL, Khan MA, Ho AC. Sociodemographic Factors Influencing Rhegmatogenous Retinal Detachment Presentation and Outcome. Ophthalmology Retina. 2020 Aug 6. doi:10.1016/j.oret.2020.08.001
108. Matsunaga DR, Su D, Sioufi K, Obeid A, Wibbelsman T, Ho AC, Regillo CD. The Timing of Large Submacular Hemorrhage Secondary to Age-Related Macular Degeneration Relative to Anti–VEGF Therapy. Ophthalmology Retina. 2020 Aug 4. doi: 10.1016/j.oret.2020.07.028
109. Chiang A, Garg SJ, Klufas MA, Ho AC, Hill L, Tsuboi M, Stoilov I. Ultra-Response to Ranibizumab: Improvement by 4 or More Steps in Diabetic Retinopathy Severity in Diabetic Retinopathy Clinical Research Network Protocol S. Ophthalmology Retina. 2020 Jul 29. doi: 10.1016/j.oret.2020.07.009
110. Patel SN, Storey PP, Levin H, Pancholy M, Obeid A, Wibbelsman TD, Kuley B, Ho AC, Hsu J, Garg SJ, Vander JF. Endophthalmitis after cataract surgery: Changes in management based on microbiologic cultures. Ophthalmology Retina. 2020 Jun 26. doi:10.1016/j.oret.2020.06.028
111. Contiliano JH, Meyer TE, Abbott DJ, Keane MF, Ho AC, Tsai MC, Khan IJ, inventors; Orbit Biomedical Ltd, assignee. Therapeutic agent delivery device with convergent lumen. United States patent US 10,639,193. 2020 May 5.
112. Charles S, Ho AC, Dugel PU, Riemann CD, Berrocal MH, Gupta S, Hamilton C, Abulon DJ. Clinical comparison of 27-gauge and 23-gauge instruments on the outcomes of pars plana vitrectomy surgery for the treatment of vitreoretinal diseases. Current Opinion in Ophthalmology. 2020 May 1;31(3):185-91. doi: 10.1097/ICU.0000000000000659
113. Hsu J, Patel SN, Wolfe JD, Shah CP, Chen E, Jenkins TL, Wibbelsman TD, Obeid A, Mikhail M, Garg SJ, Ho AC. Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial. JAMA ophthalmology. 2020 May 1;138(5):560-7. doi:10.1001/jamaophthalmol.2020.0724
114. Ammar MJ, Hsu J, Chiang A, Ho AC, Regillo CD. Age-related macular degeneration therapy: a review. Current Opinion in Ophthalmology. 2020 May 1;31(3):215-21. doi: 10.1097/ICU.0000000000000657
115. Iovino C, Au A, Chhablani J, Parameswarappa DC, Rasheed MA, Cennamo G, Cennamo G, Montorio D, Ho AC, Xu D, Querques G. Choroidal anatomical alterations following photodynamic therapy for chronic central serous chorioretinopathy: a multicenter study. American Journal of Ophthalmology. 2020 Apr 28 doi: 10.1016/j.ajo.2020.04.022
116. Pandit RR, Wibbelsman TD, Considine SP, Jenkins TL, Xu D, Levin HJ, Obeid A, Ho AC. Distribution and Practice Patterns of Retina Providers in the United States. Ophthalmology. 2020 Apr 20. doi: 10.1016/j.ophtha.2020.04.016
117. Ali F, Kasi S, Saroj N, Baker K, Thompson D, Vitti R, Berliner AJ, Metzig C, Ho AC. Impact of Posterior Vitreous Detachment on Treatment Outcomes in DME. Ophthalmology Retina. 2020 Apr 1. doi: 10.1016/j.oret.2019.12.002
118. Heier JS, Ho AC, Samuel MA, Chang T, Riemann CD, Kitchens JW, Slakter JS, Leiderman YI, Spencer R, Williams GA, Hickson-Curran SB. Safety and efficacy of subretinally administered palucorcel for geographic atrophy of age-related macular degeneration: phase 2b study. Ophthalmology Retina. 2020 Apr 1;4(4):384-93. doi: 10.1016/j.oret.2019.11.011
119. Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT. Hypotony and the Argus II retinal prosthesis: causes, prevention and management. British Journal of Ophthalmology. 2020 Apr 1;104(4):518-23. doi: 10.1136/bjophthalmol-2019-314135
120. Lee CS, Hong B, Kasi S, Aderman C, Talcott K, Adam M, Yue B, Akileswaran L, Nakamichi K, Wu Y, Rezaei KA. Prognostic utility of whole genome sequencing and polymerase chain reaction tests of ocular fluids in post-procedural endophthalmitis. American Journal of Ophthalmology. 2020 Mar 23. doi: 10.1016/j.ajo.2020.03.008
121. Ho AC, Wibbelsman TD, Pandit RR, Xu D. Trends in Ophthalmic Imaging: Implications and Outlook. American journal of ophthalmology. 2020 Feb 1;210:1-2. doi : 10.1016/j.ajo.2019.10.008
122. Patel SN, Wu C, Obeid A, Sivalingam M, Gervasio K, Wibbelsman TD, Levin H, Xu D, Regillo CD, Hsu J, Ho AC. Sociodemographic factors in neovascular age-related macular degeneration. Ophthalmology. 2020 Feb 1;127(2):280-2. doi : 10.1016/j.ophtha.2019.09.038
123. Soares RR, Mellen P, Garrigan H, Obeid A, Wibbelsman TD, Borkar D, Ho AC, Hsu J. Outcomes of Eyes Lost to Follow-up with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmology Retina. 2020 Feb 1;4(2):134-40. doi : 10.1016/j.oret.2019.07.010
124. Leroy BP, V Cideciyan A, Jacobson SG, V Drack A, Ho AC, Garafalo A, Roman AJ, Schwartz M, Biasutto P, de Wit W, Cheetham ME. Antisense oligonucleotide treatment in CEP290‐related leber congenital amaurosis. Acta Ophthalmologica. 2019 Dec;97. doi : 10.1111/j.1755-3768.2019.8296
125. Wibbelsman TD, Pandit RR, Xu D, Jenkins TL, Mellen PL, Soares RR, Obeid A, Levin H, Hsu J, Ho AC. Trends in retina specialist imaging utilization from 2012 to 2016 in the United States Medicare fee-for-service population. American Journal of Ophthalmology. 2019 Dec 1;208:12-8. doi : 10.1016/j.ajo.2019.06.026
126. Obeid A, Talcott KE, Ali FS, Gao X, Sioufi K, Wibbelsman TD, Ho AC. Macular Hole Following Subretinal Tissue Plasminogen Activator for Submacular Hemorrhage Secondary to Neovascular AMD. Ophthalmic Surgery, Lasers and Imaging Retina. 2019 Oct 8;50(9):e257-9 doi : 10.3928/23258160-20190905-18
127. Ho AC, Avery RL, Arevalo JF, Berrocal MH, Wong TP. Management of Severe Diabetic Eye Disease: A Roundtable. Retina Today. 2019 Sep;2019(September):26-36.
128. Borkar DS, Wibbelsman TD, Buch PM, Rapuano SB, Obeid A, Ho AC, Hsu J, Regillo CD, Ayres BD, Hammersmith KM, Nagra PK. Endophthalmitis rates and clinical outcomes following penetrating and endothelial keratoplasty. American journal of ophthalmology. 2019 Sep 1;205:82-90 doi : 10.1016/j.ajo.2019.05.004
129. Obeid A, Ehmann D, Adam M, Kasi S, Shahlaee A, Klufas MA, Hsu J, Mehta S, Chiang A, Garg S, Ho AC. Comparison of Residual Subfoveal Fluid by Intraoperative OCT After Macula-Involving RRD Repair Using Direct Drainage, Drainage Retinotomy, or Perfluoro-n-Octane. Ophthalmic Surgery, Lasers and Imaging Retina. 2019 Aug 19;50(8):497-503. doi : 10.3928/23258160-20190806-04
130. Gao X, Obeid A, Aderman CM, Ali FS, Vander JF, Hsu J, Ho AC. Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Macular Edema Associated With Central Retinal Vein Occlusion in Patients Age 40 Years or Younger. Ophthalmic Surgery, Lasers and Imaging Retina. 2019 Apr 18;50(4):e96-104. doi : 10.3928/23258160-20190401-13
131. Bakri SJ, Thorne JE, Ho AC, Ehlers JP, Schoenberger SD, Yeh S, Kim SJ. Safety and efficacy of anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration: a report by the American Academy of Ophthalmology. Ophthalmology. 2019;126(1):55-63. doi: 10.1016/j.ophtha.2018.07.028.
132. Rayess N, Rahimy E, Ying GS, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J. Baseline choroidal thickness as a short-term predictor of visual acuity improvement following antivascular endothelial growth factor therapy in branch retinal vein occlusion. British Journal of Ophthalmology. 2019 Jan 1;103(1):55-9. doi : 10.1136/bjophthalmol-2018-311898
133. Dugel PU, Campbell JH, Kiss S, Loewenstein A, Shih V, Xu X, Holekamp NM, Augustin AJ, Ho AC, Gonzalez VH, Whitcup SM. Association between early anatomic response to anti–vascular endothelial growth factor therapy and long-term outcome in diabetic macular edema: an independent analysis of protocol i study data. Retina (Philadelphia, Pa.). 2019 Jan;39(1):88. doi: 10.1097/IAE.0000000000002110
134. Shahlaee A, Sridhar J, Rahimy E, Shieh WS, Ho AC. Paracentral acute middle maculopathy associated with postviral Purtscher-like retinopathy. Retinal Cases and Brief Reports. 2019 Jan 1;13(1):50-3. doi: 10.1097/ICB.0000000000000529
135. Gao X, Obeid A, Adam MK, Hyman L, Ho AC, Hsu J. Loss to Follow-Up in Patients With Retinal Vein Occlusion Undergoing Intravitreal Anti-VEGF Injections. Ophthalmic Surg Lasers Imaging Retina. 2019;50(3):159-166. doi: 10.3928/23258160-20190301-05
136. Gao X, Borkar D, Obeid A, Hsu J, Ho AC, Garg SJ. Incidence of retinal artery occlusion following intravitreal antivascular endothelial growth factor injections. Acta Ophthalmol. 2019 Feb 27. doi: 10.1111/aos.14058.
137. Cideciyan AV, Jacobson SG, Drack AV, Ho AC, Charng J, Garafalo AV, Roman AJ, Sumaroka A, Han IC, Hochstedler MD, Pfeifer WL, Sohn EH, Taiel M, Schwartz MR, Biasutto P, Wit W, Cheetham ME, Adamson P, Rodman DM, Platenburg G, Tome MD, Balikova I, Nerinckx F, Zaeytijd J, Van Cauwenbergh C, Leroy BP, Russell SR. Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect. Nat Med. 2019;25(2):225-228. doi: 10.1038/s41591-018-0295-0
138. Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga PE, da Cruz L, Walter P, Augustin AJ, Chizzolini M, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R Jr, Gaucher D, Arevalo JF, Gregori NZ, Grisanti S, Özmert E, Yoon YH, Kokame GT, Lim JI, Szurman P, de Juan E Jr, Rezende FA, Salzmann J, Richard G, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS. Adverse Events Of The Argus Ii Retinal Prosthesis: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion. Retina. 2018 Nov 20. doi: 10.1097/IAE.0000000000002394
139. Talcott KE, Adam MK, Sioufi K, Aderman CM, Ali FS, Mellen PL, Garg SJ, Hsu J, Ho AC. Comparison of a Three-Dimensional Heads-Up Display Surgical Platform with a Standard Operating Microscope for Macular Surgery. Ophthalmol Retina. 2018;3(3): 244-251. doi.org/10.1016/j.oret.2018.10.016
140. Gao X, Obeid A, Aderman CM, Talcott KE, Ali FS, Adam MK, Rovner BW, Hyman L, Ho AC, Hsu J. Loss to Follow-up After Intravitreal Anti–Vascular Endothelial Growth Factor Injections in Patients with Diabetic Macular Edema. Ophthalmol Retina. 2018;3(3):230-236. doi.org/10.1016/j.oret.2018.11.002
141. Acaba-Berrocal L, Lucio-Alvarez A, Mashayekhi A, Ho AC, Dunn JP, Shields CL. Birdshot-like chorioretinopathy associated with pembrolizumab. JAMA Ophthalmol. 2018;136(10):1205–1207. doi:10.1001/jamaophthalmol.2018.1851

142. Borkar DS, Obeid A, Su DC, Storey PP, Gao X, Regillo CD, Kaisser RS, Garg SJ, Hsu J, Wills Post Injection Endophthalmitis (PIE) Study Group. Endophthalmitis rates after bilateral same-day intravitreal anti-vascular endothelial growth factor injections. Am J Ophthalmol. 2018;194:1-6. doi:10.1016/j.ajo.2018.06.022
143. Emami-Naeini P, Deaner J, Ali F, Gogte P, Kaplan R, Chen KC, Nudleman E, Grewal DS, Gupta M, Wolfe JD, Klufas MA, Yiu G, Academic Vitreoretinal Training Centers Study Group. Pneumatic retinopexy experience and outcomes of vitreoretinal fellows in the United States: a multicenter study. Ophthalmol Retina. September 2018. doi.org/10.1016/j.oret.2018.09.010
144. Bain SC, Klufas MA, Ho A, Matthews DR. Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review. Diabetes Obes Metab. September 2018. doi: 10.1111/dom.13538.
145. Gregori NZ, Callaway NF, Hoeppner C, Yuan A, Rachitskaya A, Feuer W, Ameri H, Arevalo JF, Augustin AJ, Birch DG, Dagnelie G, Grisanti S, Davis JL, Hahn P, Handa JT, Ho AC, Huang SS, Humayun MS, Iezzi R Jr, Jayasundera KT, Kokame GT, Lam BL, Lim JI, Mandava N, Montezuma SR, Olmos de Koo L, Szurman P, Vajzovic L, Wiedemann P, Weiland J, Yan J, Zacks DN. Retinal anatomy and electrode array position in retinitis pigmentosa patients after Argus II implantation: An International Study. AM J Ophthalmol. 2018;193:87-99. doi: 10.1016/j.ajo.2018.06.012.

146. Obeid A, Gao X, Ali FS, Aderman CM, Shahlaee A, Adam MK, Kasi SK, Hyman L, Ho AC, Hsu J. Loss to follow-up among patients with neovascular age-related macular degeneration who received intravitreal anti-vascular endothelial growth factor injections. JAMA Ophthalmol. 2018;136(11):1251-1259. doi: 10.1001/jamaophthalmol.2018.3578.

147. Jeannette JY, Agrón E, Clemons TE, Domalpally A, van Asten F, Keenan TD, Cukras C, Chew EY, Age-Related Eye Disease Study 2 Research Group. Natural history of drusenoid pigment epithelial detachment associated with age-related macular degeneration: Age-Related Eye Disease Study 2 Report No. 17. Ophthalmology. August 2018. doi: 10.1016/j.ophtha.2018.08.017.
148. Keenan TD, Agrón E, Domalpally D, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3^rd, Chew EY; AREDS2 Research Group. Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16. Ophthalmology. 2018;125(12):1913-1928. doi: 10.1016/j.ophtha.2018.05.028.
149. Jenkins TL, Aderman CM, Ho AC. Reversible retinal toxicity in a patient taking axitinib. Retin Cases Brief Rep. July 2018. doi:10.1097/ICB.0000000000000771
150. Ho AC, Saroj N, Baker K, Vitti R, Berliner AJ, Thompson D, Roth DB. Impact of baseline characteristics on treatment response to intravitreal aflibercept injection for wet age-related macular degeneration. Ophthalmol Retina. 2018;2(7):676-683. https://doi.org/10.1016/j.oret.2017.10.017.
151. Obeid A, Hsu J, Ehmann D, Gao X, Sridhar J, Chiang A, Park CH, Ho AC. Topical dorzolamide-timolol with intravitreous anti-vascular endothelial growth factor for retinal vein occlusion: a pilot study. Retin Cases Brief Rep. June 2018. doi:10.1097/ICB.0000000000000752.
152. Obeid A, Gao X, Ali FS, Talcott KE, Aderman CM, Hyman L, Ho AC, Hsu J. Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections. Ophthalmology. 2018;125(9):1386-1392. doi:10.1016/j.ophtha.2018.02.034.
153. Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Altaweel M, Berinstein DM, for the SCORE2 Investigator Group. Comparison of monthly vs treat-and-extend regimens for individuals with macular edema who respond well to anti-vascular endothelial growth factor medications. JAMA Ophthalmol. 2018;136(4):337-345. doi: 10.1001/jamaophthalmol.2017.6843.
154. Khan MA, Kuley A, Riemann CD, Berrocal MH, Lakhanpal RR, Hsu J, Sivalingam A, Ho AC, Regillo CD. Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease. Ophthalmology. 2018;125(3):423-431. doi:10.1016/j.ophtha.2017.09.013.
155. McKeague M, Sharma P, Ho AC. Evaluation of the macula prior to cataract surgery. Curr Opin Ophthalmol. 2018;29(1):4-8. doi:10.1097/ICU.0000000000000432.
156. McKeague M, Sharma P, Ho AC. Evaluation of the macula prior to cataract surgery. Curr Opin Ophthalmol. 2018;29(1):4-8. doi:10.1097/ICU.0000000000000432.
157. Adam MK, Weinstock BM, Kasi SK, Ehmann DS, Hsu J, Garg SJ, Ho AC, Chiang A. Patient Comfort with Yellow (577 nm) vs. Green (532 nm) Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy. Ophthalmol Retina. 2018;2(2):91-95. doi:10.1016/j.oret.2017.05.012.
158. Ho AC, Saroj N, Baker K, Vitti R, Berliner AJ, Thompson D, Roth DB. Impact of Baseline Characteristics on Treatment Response to Intravitreal Aflibercept Injection for Wet Age-Related Macular Degeneration. Ophthalmol Retina. 2017. doi:10.1016/j.oret.2017.10.017.
159. Adam MK, Shahlaee A, Samara WA, Maguire JI, Ho AC, Hsu J. En Face Versus 12-Line Radial Optical Coherence Tomography Scan Patterns For Detection Of Macular Fluid In Neovascular Age-Related Macular Degeneration. Retin Cases Brief Rep. August 2017. doi:10.1097/ICB.0000000000000616.
160. DeCroos FC, Reed D, Adam MK, Salz D, Gupta OP, Ho AC, Regillo CD. Reply. Am J Ophthalmol. 2017; 182:205-206. doi:10.1016/j.ajo.2017.07.016.
161. DeCroos FC, Reed D, Adam MK, Salz D, Gupta OP, Ho AC, Regillo CD. Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration: A Prospective Clinical Trial. Am J Ophthalmol. 2017; 180:142-150. doi:10.1016/j.ajo.2017.06.002.
162. Ho AC, Chang TS, Samuel M, Williamson P, Willenbucher RF, Malone T. Experience With a Subretinal Cell-based Therapy in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration. Am J Ophthalmol. 2017; 179:67-80. doi:10.1016/j.ajo.2017.04.006.
163. Rayess N, Ying G-S, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J, Rahimy E. Reply. Am J Ophthalmol. 2017; 176:258-259. doi:10.1016/j.ajo.2017.01.022.
164. Gallemore RP, Wallsh J, Hudson HL, Ho AC, Chace R, Pearlman J. Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial. Clin Ophthalmol Auckl NZ. 2017; 11:223-231. doi:10.2147/OPTH.S119510.
165. Ho AC, Albini TA, Brown DM, Boyer DS, Regillo CD, Heier JS. The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good. JAMA Ophthalmol. 2017;135(3):268-273. doi:10.1001/jamaophthalmol.2016.5314.
166. Adam MK, Thornton S, Regillo CD, Park C, Ho AC, Hsu J. Minimal Endoillumination Levels and Display Luminous Emittance During Three-Dimensional Heads-Up Vitreoretinal Surgery. Retina Phila Pa. 2017;37(9):1746-1749. doi:10.1097/IAE.0000000000001420.
167. Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, Ma J, Ho AC, Patel V, Whitcup SM, Dugel PU. Reply. Am J Ophthalmol. 2017;177:231-232. doi:10.1016/j.ajo.2017.02.009.
168. Samara WA, Shahlaee A, Adam MK, Khan MA, Chiang A, Maguire JI, Hsu J, Ho AC. Quantification of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography and Its Relationship with Visual Acuity. Ophthalmology. 2017;124(2):235-244. doi:10.1016/j.ophtha.2016.10.008.
169. Shahlaee A, Rahimy E, Hsu J, Gupta OP, Ho AC. Preoperative and postoperative features of macular holes on en face imaging and optical coherence tomography angiography. Am J Ophthalmol Case Rep. 2017; 5:20-25. doi:10.1016/j.ajoc.2016.10.008.
170. Cohen MN, Houston SK, Juhn A, Ho AC, Regillo CD, Vander J, Chiang A. Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion. Can J Ophthalmol J Can Ophtalmol. 2016;51(5):342-347. doi:10.1016/j.jcjo.2016.02.001.
171. Ehmann DS, Ho AC. Cataract surgery and age-related macular degeneration. Curr Opin Ophthalmol. 2017;28(1):58-62. doi:10.1097/ICU.0000000000000331.
172. Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ, Ma J, Ho AC, Patel V, Whitcup SM, Dugel PU. Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data. Am J Ophthalmol. 2016; 172:72-79. doi:10.1016/j.ajo.2016.09.012.
173. Rayess N, Rahimy E, Ying G-S, Pefkianaki M, Franklin J, Regillo CD, Ho AC, Hsu J. Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Central Retinal Vein Occlusion. Am J Ophthalmol. 2016;171:47-52. doi:10.1016/j.ajo.2016.08.026.
174. Duncan JL, Richards TP, Arditi A, da Cruz L, Dagnelie G, Dorn JD, Ho AC, Olmos de Koo LC, Barale P-O, Stanga PE, Thumann G, Wang Y, Greenberg RJ. Improvements in vision-related quality of life in blind patients implanted with the Argus II Epiretinal Prosthesis. Clin Exp Optom. 2017;100(2):144-150. doi:10.1111/cxo.12444.
175. Dagnelie G, Christopher P, Arditi A, da Cruz L, Duncan JL, Ho AC, Olmos de Koo LC, Sahel J-A, Stanga PE, Thumann G, Wang Y, Arsiero M, Dorn JD, Greenberg RJ, Argus® II Study Group. Performance of real-world functional vision tasks by blind subjects improves after implantation with the Argus® II retinal prosthesis system. Clin Experiment Ophthalmol. 2017;45(2):152-159. doi:10.1111/ceo.12812.
176. Shieh W-S, Sridhar J, Hong BK, Maguire JI, Rahimy E, Shahlaee A, Ho AC, Hsu J, Regillo CD, Chiang A. Ophthalmic Complications Associated with Direct Oral Anticoagulant Medications. Semin Ophthalmol. 2017;32(5):614-619. doi:10.3109/08820538.2016.1139738.
177. da Cruz L, Dorn JD, Humayun MS, Dagnelie G, Handa J, Barale P-O, Sahel J-A, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Ho AC, Brown G, Haller J, Regillo C, Del Priore LV, Arditi A, Greenberg RJ, Argus II Study Group. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial. Ophthalmology. 2016;123(10):2248-2254. doi:10.1016/j.ophtha.2016.06.049.
178. Rahimy E, Shahlaee A, Ehmann D, Rayess N, Fineman MS, Garg SJ, Ho AC, Hsu J. Early Optical Coherence Tomography Findings after Vitreomacular Traction Release. Ophthalmology. 2016;123(9):2046-2047. doi:10.1016/j.ophtha.2016.04.045.
179. Rahimy E, Shahlaee A, Khan MA, Ying G-S, Maguire JI, Ho AC, Regillo CD, Hsu J. Reply. Am J Ophthalmol. 2016;168:291-292. doi:10.1016/j.ajo.2016.05.014.
180. Inoue M, Jung JJ, Balaratnasingam C, Dansingani KK, Dhrami-Gavazi E, Suzuki M, de Carlo TE, Shahlaee A, Klufas MA, El Maftouhi A, Duker JS, Ho AC, Maftouhi MQ-E, Sarraf D, Freund KB, COFT-1 Study Group. A Comparison Between Optical Coherence Tomography Angiography and Fluorescein Angiography for the Imaging of Type 1 Neovascularization. Invest Ophthalmol Vis Sci. 2016;57(9):OCT314-323. doi:10.1167/iovs.15-18900.
181. Shahlaee A, Samara WA, Sridhar J, Kasi SK, Hsu J, Ho AC. Accentuation of optical coherence tomography angiography projection artefacts on hyper-reflective retinal layers. Acta Ophthalmol (Copenh). July 2016. doi:10.1111/aos.13164.
182. Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC. Worldwide Argus II implantation: recommendations to optimize patient outcomes. BMC Ophthalmol. 2016 May 6;16(1):52.
183. Khan MA, Shahlaee A, Toussaint B, Hsu J, Sivalingam A, Dugel PU, Lakhanpal RR, Riemann CD, Berrocal MH, Regillo CD, Ho AC. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease Reply. Am J Ophthalmol. 2016 Apr 1;164:148-9.
184. Calvo CJ, Sridhar J, Shahlaee A, Ho AC. Reduction of diabetic macular edema in the untreated fellow eye following intravitreal injection of aflibercept. Ophthalmic Surg Lasers Imaging Retina. 2016;47:474-476
185. Sridhar J, Shahlaee A, Ehmann D, Samara WA, Rahimy E, Ho AC, Chiang A. En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography Imaging of Taxane-Associated Cystoid Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2016;47(2):176-179.
186. Shahlaee A, Pefkianaki M, Hsu J, Ho AC. Measurement of Foveal Avascular Zone Dimensions and its Reliability in Healthy Eyes Using Optical Coherence Tomography Angiography. Am J Ophthalmol. 2016;161:50-55.e1.
187. Shahlaee A, Hong BK, Ho AC. Optical Coherence Tomography Angiography Features of Branch Retinal Vein Occlusion. Retin Cases Brief Rep. March 2016. doi:10.1097/ICB.0000000000000297.
188. Shahlaee A, Samara WA, Hsu J, Say EA, Khan MA, Sridhar J, Hong BK, Shields CL, Ho AC. In Vivo Assessment of Macular Vascular Density in Healthy Human Eyes Using Optical Coherence Tomography Angiography. Am J Ophthalmol. February 2016. doi:10.1016/j.ajo.2016.02.018.
189. Samara WA, Shahlaee A, Sridhar J, Khan MA, Ho AC. En Face Optical Coherence Tomography of Bilateral Myopic Macular Retinoschisis. Retina (Philadelphia, Pa). February 2016. doi:10.1097/IAE.0000000000001007.
190. Samara WA, Shahlaee A, Sridhar J, Khan MA, Ho AC, Hsu J. Quantitative Optical Coherence Tomography Angiography Features and Visual Function in Eyes with Branch Retinal Vein Occlusion. Am J Ophthalmol. March 2016. doi:10.1016/j.ajo.2016.03.033.
191. Rahimy E, Shahlaee A, Khan MA, Ying GS, Maguire JI, Ho AC, Regillo CD, Hsu J. Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema. Am J Ophthalmol. 2016;164:118-127.e2.
192. Rahimy E, Rayess N, Ho AC, Regillo CD. Treatment Outcomes for Neovascular Age-Related Macular Degeneration Patients with Initial Vision Better than 20/40 Using A Treat-And-Extend Regimen. Retina (Philadelphia, Pa). 2016;36(5):875-880.
193. Khan MA, Ho AC, Spirn MJ. Cotton-Wool Spots After Use of Macitentan for Pulmonary Arterial Hypertension. Retin Cases Brief Rep. January 2016. doi:10.1097/ICB.0000000000000273.
194. Khan MA, Shahlaee A, Toussaint B, Hsu J, Sivalingam A, Dugel PU, Lakhanpal RR, Riemann CD, Berrocal MH, Regillo CD, Ho AC. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease. Am J Ophthalmol. 2016;161:36-43.e1-e2.
195. Hsu J, Khan MA, Shieh WS, Chiang A, Maguire JI, Park CH, Garg SJ, Ho AC, Kaiser RS. Effect of Serial Intrasilicone Oil Bevacizumab Injections in Eyes With Recurrent Proliferative Vitreoretinopathy Retinal Detachment. Am J Ophthalmol. 2016;161:65-70.e1-e2.
196. Ghodasra DH, Chen A, Arevalo JF, Birch DG, Branham K, Coley B, Dagnelie G, de Juan E, Devenyi RG, Dorn JD, Fisher A, Geruschat DR, Gregori NZ, Greenberg RJ, Hahn P, Ho AC, Howson A, Huang SS, Iezzi R, Khan N, Lam BL, Lim JI, Locke KG, Markowitz M, Ripley AM, Rankin M, Schimitzek H, Tripp F, Weiland JD, Yan J, Zacks DN, Jayasundera KT. Worldwide Argus II implantation: recommendations to optimize patient outcomes. BMC Ophthalmol. 2016;16(1):52.
197. Geruschat DR, Richards TP, Arditi A, da Cruz L, Dagnelie G, Dorn JD, Ho AC, et al. An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years. Clin Exp Optom. January 2016. doi:10.1111/cxo.12359.
198. Ehmann D, Shahlaee A, Ho AC. Cell therapy for retinal disease. Curr Opin Ophthalmol. 2016;27(3):185-190.
199. Bagheri N, Shahlaee A, Sridhar J, Ho AC. En face optical coherence tomography and angiography of talc retinopathy. Acta Ophthalmol. 2016;94(1):103-104.
200. Garg SJ, Dollin M, Storey P, Pitcher JD, Fang-Yen NH, Vander J, Hsu J, Post-Injection Endophthalmitis Study Team. Microbial Spectrum and Outcomes of Endophthalmitis After Intravitreal Injection Versus Pars Plana Vitrectomy. Retina Phila Pa. 2016;36(2):351-359. doi:10.1097/IAE.0000000000000694.
201. Yeh S, Kim SJ, Ho AC, et al. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122(4):769-778.
202. Witkin AJ, Rayess N, Garg SJ, Maguire JI, Storey P, Kaiser RS, Hsu J, Vander JF, Ho AC. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment. Semin Ophthalmol. September 2015:1-7. doi:10.3109/08820538.2015.1072222.
203. Sridhar J, Shahlaee A, Rahimy E, Hong BK, Khan MA, Maguire JI, Dunn JP, Mehta S, Ho AC. Optical Coherence Tomography Angiography and En Face Optical Coherence Tomography Features of Paracentral Acute Middle Maculopathy. Am J Ophthalmol. 2015;160(6):1259-1268.e2
204. Sharma P, Juhn A, Houston SK, Fineman M, Chiang A, Ho AC, Regillo CD. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes. Am J Ophthalmol. 2015;159(5):861-867.e2.
205. Rovner BW, Casten RJ, Murchison AP, Ho AC, Henderer J, Haller JA. Depression and Memory Loss in African Americans with Diabetic Retinopathy. J Am Geriatr Soc. 2015;63(6):1249-1251.
206. Regillo CD, Busbee BG, Ho AC, Ding B, Haskova Z. Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration. Am J Ophthalmol. 2015;160(5):1014-1023.e2.
207. Rayess N, Rahimy E, Ho AC. Spectral-domain optical coherence tomography features of bilateral chorioretinitis sclopetaria. Ophthalmic Surg Lasers Imaging Retina. 2015;46(2):253-255.
208. Pitcher JD, Witkin AJ, DeCroos FC, Ho AC. A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study. Br J Ophthalmol. 2015;99(6):848-852.
209. Pitcher JD, Khan MA, Storey PP, Storey PP, Hsiao-Fang-Yen N, Dollin ML, Hsu J, Ho AC, Regillo CD, Garg SJ. Contemporary Management of Rhegmatogenous Retinal Detachment Due to Giant Retinal Tears: A Consecutive Case Series. Ophthalmic Surg Lasers Imaging Retina. 2015;46(5):566-570.
210. Khan MA, Shahlaee A, Ho AC. Reopening of a Full-Thickness Macular Hole 2 Years After Pharmacologic Closure With Ocriplasmin. JAMA Ophthalmol. 2015;133(11):1362-1364.
211. Khan MA, Rahimy E, Shahlaee A, Hsu J, Ho AC. En Face Optical Coherence Tomography Imaging of Deep Capillary Plexus Abnormalities in Paracentral Acute Middle Maculopathy. Ophthalmic Surg Lasers Imaging Retina. 2015;46(9):972-975.
212. Khan MA, Ho AC, Haller JA. Ten-year Follow-Up of a Subretinal Silicon Prosthesis for Retinitis Pigmentosa. Ophthalmology. 2015;122(10):2114.
213. Houston SK, Rayess N, Cohen MN, Ho AC, Regillo CD. Influence of Vitreomacular Interface on Anti-Vascular Endothelial Growth Factor Therapy Using Treat And Extend Treatment Protocol for Age-Related Macular Degeneration (Vintrex). Retina (Philadelphia, Pa). 2015;35(9):1757-1764.
214. Ho AC, Puliafito CA, Ho AC. 8 Questions with Dr. Puliafito. Ophthalmic Surg Lasers Imaging Retina. 2015;46(1):145-147.
215. Ho AC, Humayun MS, Dorn JD, et al. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind. Ophthalmology. 2015;122(8):1547-1554.
216. Greven MA, Garg S, Chiu B, Shah SP, Wolfe J, Fine HF, Roth DB, Robinson J, Mong J, Hsu J, Regillo CD, Ho AC, Haller JA. Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study. Br J Ophthalmol. December 2015. doi:10.1136/bjophthalmol-2015-307701.
217. Cohen MN, Rahimy E, Ho AC, Garg SJ. Management of Symptomatic Floaters: Current Attitudes, Beliefs, and Practices Among Vitreoretinal Surgeons. Ophthalmic Surg Lasers Imaging Retina. 2015;46(8):859-865.
218. Chen X, Rahimy E, Sergott RC, Nunes RP, Souza EC, Choudhry N, Houston SK 3rd, Munk MR, Fawzi AA, Mehta S, Hubschman J, Ho AC, Sarraf D. Spectrum of Retinal Vascular Diseases Associated With Paracentral Acute Middle Maculopathy. Am J Ophthalmol. 2015;160(1):26-34.e1.
219. Chang W, Garg SJ, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC, Maturi R. Reply: To PMID 24531021. Am J Ophthalmol. 2015;159(2):404-405.
220. Rayess N, Houston SK 3rd, Gupta OP, Ho AC, Regillo CD. Treatment Outcomes After 3 Years in Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen. Am J Ophthalmol. 2015 Jan;159(1):3-8.
221. Rayess N, Rahimy E, Ying GS, Bagheri N, Ho AC, Regillo CD, Vander JF, Hsu J. Baseline choroidal thickness as a predictor for response to anti-vascular endothelial growth factor therapy in diabetic macular edema. Am J Ophthalmol. 2015 Jan;159(1):85-91.
222. Ali Khan M, Skidmore K, Ho AC. Perioperative retina evaluation of the cataract surgery patient. Curr Opin Ophthalmol. 2015 Jan;26(1):39-44. doi:10.
223. Ho AC, Busbee BG, Regillo CD, Wieland MR, Van Everen SA, Li Z, Rubio RG, Lai P; HARBOR Study Group. Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration. Ophthalmology. 2014 Nov;121(11):2181-92.
224. Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Ho AC, Tasman WS. Low vision depression prevention trial in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2014 Nov;121(11):2204-11.
225. Folgar FA, Jaffe GJ, Ying GS, Maguire MG, Toth CA; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. Comparison of optical coherence tomography assessments in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014 Oct;121(10):1956-65.
226. Storey P, Alshareef R, Khuthaila M, London N, Leiby B, DeCroos C, Kaiser R; Wills PVR Study Group. Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy. Retina. 2014 Oct;34(10):1945-51.
227. Rahimy E, Sarraf D, Dollin ML, Pitcher JD, Ho AC. Paracentral acute middle maculopathy in nonischemic central retinal vein occlusion. Am J Ophthalmol. 2014 Aug;158(2):372-380.
228. Kim BJ, Ying GS, Huang J, Levy NE, Maguire MG; CATT Research Group. Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT). Am J Ophthalmol. 2014 Jul;158(1):128-135.
229. Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol. 2014 Jun;157(6):1250-7.
230. Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group. VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). JAMA Ophthalmol. 2014 May;132(5):521-7.
231. Wong SC, Lee TC, Heier JS, Ho AC. Endoscopic vitrectomy. Curr Opin Ophthalmol. 2014 May;25(3):195-206.
232. Khan MA, Pitcher JD 3rd, Kawut SM, Ho AC. Bilateral cotton wool spots after use of an endothelin receptor antagonist. Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):156-9.
233. Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, Ho AC, Ogura Y, Simader C, Jaffe GJ, Slakter JS, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Sowade O, Zeitz O, Norenberg C, Sandbrink R, Heier JS. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology. 2014 Jan;121(1):193-201.
234. Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Schmidt-Erfurth U. Author reply: To PMID 23084240. Ophthalmology. 2014 Jan;121(1):e5-e6.
235. Wong SC, Lee TC, Heier JS, Ho AC. Endoscopic vitrectomy. Curr Opin Ophthalmol. 2014 May;25(3):195-206. doi: 10.1097/ICU.0000000000000052.
236. Rahimy E, Sarraf D, Dollin ML, Pitcher JD, Ho AC. Paracentral Acute Middle Maculopathyin Nonischemic Central Retinal Vein Occlusion. Am J Ophthalmol. 2014 Apr 30. pii: S0002-9394(14)00227-X. doi: 10.1016/j.ajo.2014.04.024.
237. Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, Ho AC, Ogura Y, Simader C, Jaffe GJ, Slakter JS, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Sowade O, Zeitz O, Norenberg C, Sandbrink R, Heier JS. Intravitreal aflibercept injection for neovascular age-related macular degeneration ninety-six-week results of the VIEW studies. Ophthalmology. 2014 Jan;121(1):193-201. doi: 10.1016/j.ophtha.2013.08.011. Epub 2013 Sep 29.
238. Khan MA, Pitcher JD 3rd, Kawut SM, Ho AC. Bilateral cotton wool spots after use of an endothelin receptor antagonist. Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):156-9. doi: 10.3928/23258160-20140124-01. Epub 2014 Jan 23.
239. Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Ho AC, Tasman WS. Improving function in age-related macular degeneration: a randomized clinical trial. Ophthalmology. 2013 Aug;120(8):1649-55. doi: 10.1016/j.ophtha.2013.01.022. Epub 2013 May 1.
240. Gerstenblith AT, Baskin DE, Shah CP, Wolfe JD, Fineman MS, Kaiser RS, Ho AC. Electroretinographic effects of Omega-3 Fatty Acid supplementation on dry age-related macular degeneration. JAMA Ophthalmol. 2013 Mar;131(3):365-9. doi: 10.1001/jamaophthalmol.2013.642.
241. Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol. 2014 Feb 13. pii: S0002-9394(14)00070-1. doi: 10.1016/j.ajo.2014.02.007.
242. Mehta S, Hariharan, L, Ho AC, Kempen JH. Peripapillary Choroidal Neovascularization in Pars Planitis. Journal of Ophthalmic Inflammation and Infection, Spring 2013-Volume 3-Issue 1-pp 3-13.
243. Kim SJ, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS, Recchia FM. Interventions for toxoplasma retinochoroiditis: a report by the American Academy of Ophthalmology. Ophthalmology, 2013 Feb:120(2):371-8.
244. Busbee BG, Ho AC, Brown DM, Heier JS, Suner IJ, Li Z, Rubio RG, Lai P; HARBOR Study Group. Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration. Ophthalmology. 2013 January 23.
245. Ho AC, Scott IU, Kim, SJ. Brown MM, Ip MS, Recchia, FM, Brown GC. Anti-Vascular Endotheilal Growth Factor Pharmacotherapy for Diabetic Macular Edema: a report by the American Academy of Ophthalmology. Ophthalmology 2012 Oct;119(1):2179-88.
246. Witkin AJ, Fineman M, Ho AC, Spirn M. A Novel Method of Draining Intraoperative Choroidal Detachment During 23-gauge Pars Plana Vitrectomy. Arch Ophthalmol. 2012 Aug 1:130(8):1048-50.
247. Tibbetts, MD.; Samuel M A.; Chang TS.; Ho, AC. Stem Cell Therapy for Retinal Disease. Current Opinion in Ophthalmology, May 2012, Volume 3, Issue 3, Pgs. 226-234.
248. Kaiser RS, Gupta, OP, Regillo CD, Ho AC, Fineman MS, Vander JF, McNamara JA, Brown GC. Ranibizumab for Eyes Previously Treated With Pegaptanib or Bevacizumab Without Clinical Response. Ophthalmic Surg Lasers Imaging. January-February 2012.
249. Nguyen, QD, Brown DM, Marcus DM, Boyer DS. Patel S, Feiner L, Gibson, A, Rundle, AC, Hopkins, JJ, Rubio, RG, Ehrlich JS, RISE and RIDE Research Group. Ranibizumab for Diabetic Macular Edema: Results from 2 Phase III Randomized Trials: RISE and RIDE. J Ophth.2011.12.039.
250. Fenton GL, Ho AC, Volpe NJ. Outer Retinal Dysfunction in A Patient with the 15257 Mitochondrial DNA Mutation. Retinal Cases and Brief Reports, Spring 2011-Volume 5- Issue 2 - pp 104-107.
251. Armstrong B, Fecarotta C, Ho AC, Baskin DE. Evolution of Severe Lightning Maculopathy Visualized With Spectral Domain Optical Coherence Tomography. Ophthalmic Surg Lasers Imaging 2010; 41:S70-S73.
252. Ehlers JP, Spirn MJ, Shah CP, Fenton GL, Baker PS, Regillo CD, Ho AC. Ranibizumab for Exudative Age-Related Macular Degeneration in Eyes Previously Treated with Alternative Vascular Endothelial Growth Factor Inhibitors. Ophthalmic Surgery, Lasers Imaging. March-April 2010.
253. Recchia FM, Scott IU, Brown GC, MM Brown, Ho AC, Ip MS. Small-Gauge Pars Plana Vitrectomy: A Report by the American Academy of Ophthalmology. Ophthalmology September 2010, Volume 117, Issue 9, Pages 1851-1857.
254. Rezeq SS, Vander JF, Hsu J, Regillo CD, Ho AC, Garg SJ, Spirn MJ. Iatrogenic retinal breaks (letter). Ophthalmology 2011; 118: 1696 -1697.
255. Brown DB, Campochiaro PA, Bhisitkul RB, Ho AC, Gray S, Saroj N, Adamis AP, Rubio RG. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology 2011; 118: 1594-1602.
256. Ho AC, An Evidence-based Approach for RVO: Corticosteroids, Implants, and Anti-VEGF Therapies. Retina Today Supplement, 2011 May/June: 3-6.
257. Chen W, Stambolian D, Edwards AO, Branham, KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, Tan PL, Conley YP, Kanda A, Kopplin L, Li Y, Augustaitis KJ, Karoukis AJ, Scott WK, Agarwal A, Kovach JL, Schwartz SG, Postel, EA, Brooks M, Baratz KH, Brown WL, Brucker, AJ, Orlin A, Brown G, Ho A, Regillo C, Donoso L, Tian L, Kaderli B, Hadley D, Hagstrom SA, Peachey NS, Klein R, Klein BEK, Gotoh N, Yamashiro K, Ferris III F, Fagerness JA, Reynolds R, Farrer LA, kim, IK Miller JW, Corton M, Carracedo A, Sanchez-Salorio M, Pugh EW, Doheny KF, Brion M, DeAngelis MM, Weeks, DE, Zack DJ, Chew EYE, Heckenlively JR, Yoshimura N, Iyengar SK, Francis PJ, Katsanis N, Seddon JM, Haines JL, Gorin MB. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. PNAS 2010:107(16):7401-7406.
258. Hadley D, Orlin A, Brown G, Brucker AJ, Ho AC, Regillo CE, Donoso LA, Tian L., Kaderli B, Stambolian D, Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26. Invest Ophthalmol Vis Sci. 2010 Apr; 51(4): 2191-6.
259. Ehlers JP, Spirn MJ, Shah CP, Fenton GL, Baker PS, Regillo CD, Ho AC, Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors. Ophthalmic Surg Lasers Imaging. 2010 Mar-Apr ;41(2): 182-9.
260. Barbazetto IA, Saroj N, Shapiro H, Wong P, Ho AC, Freund KB, Incidence of new choroidal neovascularization in Fellow Eyes of Patients Treated in the MARINA and ANCHOR Trials. Am J Ophthalmol. 2010 Apr 6.
261. Kaiser RS, Prenner J, Scott IU, Brucker AJ, Flynn HW Jr., Ho AC, Regillo CD, Capone A. Avery R, Eliott D, Dugel P, Pollack J., The Microsurgical Safety Task Force: Evolving Guidelines for Minimizing the Risk of Endophthalmitis Associated with Microincisional Vitrectomy surgery. Retina 2010; Apr 30(4):692-9.
262. Fenton GL, Ho AC, Volpe NJ, Outer Retinal Dysfunction In A Patient With The 15257 Mitochondrial DNA Mutation. Retinal Cases and Brief Reports. Spring 2011:5:2:104-107.
263. Fintelmann RE, Maguire JI, Ho AC, Chew HF, Ayres BD, Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea. 2009 Sept;28(8):877-8.
264. Ho A, Volpe N. Outer Retina Dysfunction In A Patient with the 15257 Mitochondrial DNA Mutation CABR 208-1461R1. Retina Cases and Briefs Reports. 2010 June:149(6); 939-946.
265. Chen E, Ho AC, Garg SJ, Brown GC, Kaiser RS, Streptococcus mitis endophthalmitis presenting as frosted branch angilitis after intravitreal pegaptanib sodium injection. Ophthalmic Surg Lasers Imaging. 2009 Mar-Apr; 40(2): 1924.
266. Ehlers JP, Kunimoto DY, Ittoop S, Maguire JI, Ho AC, Regillo CD; Metallic intraocular foreign bodies: characteristics, interventions, and prognostic factors for visual outcome and globe survival. Am J Ophthalmol. 2008 Sept;146(3):427-33.
267. Ip MS, Scott IU, Brown GC, Brown MM, Ho AC, Huang SS, Recchia FM. Anti-Vascular Endothelial Growth Factor Pharmacotherapy for Age-Related Macular Degeneration. Ophthalmology. August 2008: 1837-1844.
268. Gupta OP, Ho AC, Kaiser PK, Regillo CD, Chen S, Dyer DS, Dugel PU, Gupta S, Pollack JS. Short-term outcomes of 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2008 Aug;146(2):193-197.
269. Shah CP, Ho AC, Regillo CD, Fineman MS, Vander JF, Brown GC. Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment. Retina. 2008 May;28(5):723-9.
270. Hsu J, Kaiser, RS, Sivalingam A, Abraham P, Fineman MS, Samuel MA, Vander JF, Regillo CD, Ho AC. Intravitreal bevacizumab (Avastin) in central retinal vein occlusion. Retina. 2007 Oct; 27(8):1013-19.
271. Ehlers JP, Fintak DR, Gupta OP, Regillo CD, Fineman MS, Ho AC. Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2007 Sept-Oct;38(5):371-7.
272. Gupta OP, Weichel ED, Regillo CD, Fineman MS, Kaiser RS, Ho AC, McNamara JA, Vander JF. Postoperative complications associated with 25-gauge pars plana vitrectomy. Ophthalmic Surg Lasers Imaging. 2007 July-Aug;38(4):270-5
273. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP,Schneider S; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5;355(14):1432-44.
274. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY; MARINA Study Group, Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006 Oct 5;355(14):1419-31.
275. CAPT Study Group. Laser Treatment in Patients with Bilateral Drusen. The Complications of AMD Prevention Trial. Ophthalmol 2006; 113: 1974 – 1986.
276. Aizman A, Johnson MW, Olsen TW, Ho AC, Davis JL. Diagnostic and therapeutic challenges. High grade fever and bronchitis. Retina. 2006 Mar;26(3):345-51.
277. Hurley BR, McNamara JA, Fineman MS, Ho AC, Tasman W, Kaiser RS, Vander JF, Regillo CD, Brown GC. Laser Treatment for Retinopathy of Prematurity: Evolution in Treatment Technique Over 15 Years. Retina. 2006 Sep;26(7 Suppl):S16-7.
278. Chhabra S, Kunimoto DY, Kazi L, Regillo CD, Ho AC, Belmont J, Maguire J, Vander J, Brown GC. Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates. Am J Ophthalmol. 2006 Nov;142(5):852-4.
279. Fintak DR, Ho AC. Perioperative and operative considerations in diabetics. Ophthalmol Clin North Am. 2006 Dec;19(4):427-34.
280. Weichel ED, Martidis A, Fineman MS, McNamara JA, Park CH, Vander JF, Ho AC, Brown GC. Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle for primary repair of pseudophakic retinal detachment. Ophthalmology. 2006 Nov;113(11):2033-40.
281. Rodrigues EB, Rossi EE, Grumann Junior A, Meyer CH, Ho AC. Treatment of neovascular age-related macular degeneration with antiangiogenic drugs. Arq Bras Oftalmol. 2006 Sep-Oct;69(5):756-65.
282. D'Amico DJ; VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group; Patel M, Adamis AP, Cunningham ET Jr, Guyer DR, Katz B. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology. 2006 Jun;113(6):1001-1006.
283. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group. Year 2 Efficacy Results of 2 Randomized Controlled Clinical Trials of Pegaptanib for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2006 Jun;113(6):992-1001.
284. Smith BT, Vander JE, Regillo CD, Ho AC. Evaluation of the potential acuity meter in predicting visual acuity after photodynamic therapy for choroidal neovascularization. Ophthalmic Surg Lasers Imaging. 2006 Jan-Feb;37(1):6-11.
285. Lam A, Lee HC, Ho AC, Regillo CD, McNamara JA, Fineman MD. Photodynamic therapy in young patients. Ophthalmic Surg Lasers Imaging. 2006 May-Jun;37(3):182-9.
286. Hurley BR, McNamara JA, Fineman MS, Ho AC, Tasman W, Kaiser RS, Vander JF, Regillo CD. Laser Treatment for Retinopathy of Prematurity: Evolution of Treatment Technique over 15 years. Retina. 2006 Sep;26.
287. Ho AC. Photodynamic Therapy with Verteportin combined with Intravitreal Injection of Triamcinolone Acetonide for Choroidal Neovascularization. Critical Review. Evid Based Ophthalmol 2005.
288. randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005 Oct; 112(10):1747-57.
289. Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D’Amico DJ, Goldbaum M, Guyer DR, Katz B, Patel M, Schwartz SD, Macugen Diabetic Retinopathy Study Group. A phase II
290. Recchia FM, Busbee BG, Pearlman RB, Carvalho-Recchia CA, Ho AC. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol. 2005 Mar;123(3):341-6.
291. Smith BT, Belani S, Ho AC. Ultraviolet and near-blue light effects on the eye. Int Ophthalmol Clin. 2005 Winter; 45(1):107-15.
292. Smith BT, Belani S, Ho AC. Light energy, cataract surgery, and progression of age-related macular degeneration. Curr Opin Ophthalmol. 2005 Jun;16(3):166-9.
293. Ho AC. Effect of Lesion Size, Visual Acuity, and Lesion Composition on Visual Acuity Change With and Without Verteporfin Therapy for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: TAP and VIP Report No. 1. Critical Review. Evid Based Ophthalmol 2004.
294. Gragoudos ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR and the VEGF Inhibition Study in Ocular Neovascularization Study Group. Pegaptanib for Neovascular Age-Related Macular Degeneration. N Engl J Med 2004: 351: 2805 - 2816.
295. VAM Study Writing Committee (Ho AC, Writing Committee Chairman). Verteporfin Therapy in Age-Related Macular Degeneration (VAM): An Open-label Multicenter Photodynamic Therapy Study of 4,435 Patients. Retina. 2004 Aug;24(4):512-520.
296. D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger S, Luna S, Robertson SM, Russell S, Singerman L, Slakter JS, Sullivan EK, Yannuzzi L, Zilliox P; Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for the treatment of neovascularization in age-related macular degeneration (AMD): twelve-month clinical outcomes. Retina. 2003;110(1):2372 -83.
297. Lee HC, Liu M, Ho AC. Idiopathic Juxtafoveal Telangiectasis in Association With Celiac Sprue. Arch Ophthalmol. 2004;122:411-413.
298. Liu M, Lee H, HertelR, Ho AC. Retinal Detachment From Inadvertent Intraocular Injection of Botulinum Toxin A. Am J Ophthalmol. 2004 Jan;137(1):201-2.
299. Ho AC. “Effect of Lesion Size, Visual Acuity, and Lesion Composition on Visual Acuity Change With and Without Verteporfin Therapy for CNV Secondary to AMD: TAP and VIP Report No. 1. Am J Ophthalmol 2003; 136: 407 – 418. Evidence-Based Eye Care 2004, 5(1):13-15.
300. Ho AC, Seddon JM, Cote J, Davis N, Rosner B. Progression of Age-Related Macular Degeneration: Association with Body Mass Index, Waist Circumference, and Waist-Hip Ratio. Arch Ophthalmol 2003; 121: 785 - 792.” Evidence-Based Eye Care 2003,4(4):202-203.
301. Prenner JL, Rosenblatt BJ, Tolentino MJ, Ying G-S, Javornik NB, Maguire MG, Ho AC and the CNVPT Research Group. Risk Factors for Choroidal Neovascularization and Vision Loss in the Fellow Eye Study of the CNVPT. Retina 2003; 23: 307 – 314.
302. Ho AC. " Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin Therapy of Subfoveal CNV in Patients with AMD: Additional Information Regarding Baseline Lesion Composition’s Impact on Vision Outcomes – TAP Report No. 3.” Review. Evidence-Based Eye Care 2003, 4(2):70-71.
303. Maguire MG, Ying G-S, Javornik NB, Ho AC, Fine SL for the Choroidal Neovascularization Prevention Trial Research Group. Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Ophthalmology. 2003;110(5):971-8.
304. Sharma, MC, Ho, AC. Agreement Among Ophthalmologists in Evaluating Fluorescein Angiograms in Patients with Neovascular Age-Related Macular Degeneration for Photodynamic Therapy Eligibility (Flap-Study). Review. Evidence-Based Eye Care 2003, 4(3):162-163.
305. Nagra P, Ho AC, Dugan JD. Lipemia Retinalis Associated with Branch Retinal Vein Occlusion. Am J Ophthalmol 2003: 135: 539 – 542.
306. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology. 2003: 110:979-86.
307. D'Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger S, Luna S, Robertson SM, Russell S, Singerman L, Slakter JS, Sullivan EK, Yannuzzi L, Zilliox P; Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy. Retina. 2003;23(1):14-23.
308. Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina. 2002 Apr;22(2):143-52.
309. Ho AC and Regillo CD. Clinical Challenges Commentary. Bilateral Retinal Hemorrhages in an 18 year old woman. Surv Ophthalmol 2002: 47: 590 – 593.
310. Shuler MF, Borrillo JL, Ho AC. Photodynamic therapy update. Curr Opin Ophthalmol 2001, 12(3):202-6.
311. Benson WE, Regillo CD, Vander JF, Tasman W, Smith AF, Brown GC, Ho AC, McNamara JA. Patient initiated second medical opinions: Their necessity and economic cost. Retina 2001; 21: 633 – 638.
312. Kaiser RS, Berger JW, Maguire MG, Shin DS, Ho AC, Javornik NB, Fine SL and the Choroidal Neovascularization Prevention Trial Research Group. Laser burn intensity and the risk for choroidal neovascularization in the CNVPT Fellow Eye Study. Arch Ophthalmol 2001; 119:826-832.
313. Vander JF, Ho AC, McNamara JA, Regillo CD, Brown GC, Benson WE, Tasman W. Diabetes and retinopathy. Ophthalmology. 2000 Dec;107(12):2120-2.
314. Recchia F, Ho AC. Laser treatment of retinal venous occlusive disease. Comprehensive Ophthalmology 2000; 1: 109 – 118.
315. Ho AC, Benson WE, Wong J. Unusual Immunogammopathy Maculopathy. Ophthalmology 2000; 107: 1099 – 1103.
316. Kaiser RS, Maguire MG, Grunwald JE, Lieb D, Jani B, Brucker AJ, Maguire AM, Ho AC, Fine SL. One-Year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy. Am J Ophthalmol 2000; 129: 178 – 185.
317. Owsley C, Jackson GR, Cideciyan AV, Huang Y, Fine SL, Ho AC, Maguire MG, Lolley V, Jacobson SG. Psychophysical evidence for rod vulnerability in age-related macular degeneration. Invest Ophth Vis Sci 2000; 41: 267 - 273.
318. Fine SL, Berger JW, Maguire MG, Ho AC. Age-related macular degeneration. N Engl J Med 2000; 342: 483 - 492.
319. Sharma MC, Ho AC. Macular fibrosis associated with talc retinopathy. Am J Ophthalmol 1999; 128: 517 – 519.
320. Ho AC, Maguire MG, Yoken J, Lee ML, Shin DS, Javornik NB, Fine SL and the Choroidal Neovascularization Prevention Trial Study Group. Laser induced drusen reduction improves visual function at 1 year. Ophthalmology 1999; 106: 1367 - 1374.
Ccccccccccccccccccccccccccccccccccccccccccccccccc2
321. Grunwald JE, Hariprasad S, Dupont J, Maguire MG, Fine SL, Brucker AJ, Maguire AM, Ho AC. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998; 39: 385 - 390.
322. Ho AC, Guyer DR, Fine SL. Macular Hole. Survey Ophthalmology 1998; 42: 393-416.
323. Choroidal Neovascularization Prevention Trial Study Group. Choroidal neovascularization in the CNVPT. Ophthalmology 1998; 105: 1364 - 1372.
324. Choroidal Neovascularization Prevention Trial Study Group. Laser Treatment in Eyes with Large Drusen: Short Term Effects from a Pilot Randomized Clinical Trial. Ophthalmology 1998; 105: 11-23.
325. Mousa SA, Kerr JS, Ho AC. Angiogenesis in Vascular Disorders. Current Research in Vascular Diseases 1997; 3: 1 - 5.
326. Ho AC, Maguire AM, Yannuzzi LA, Fisher YL, Galetta S, Fisher YL, Sergott RC. Rapidly progressive optic disc neovascularization after diabetic papillopathy. Am J Ophthalmol 1995; 120: 673 - 675.
327. Ho AC, Pisacano K, Yannuzzi LA, DeRosa JT. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology 1995; 102: 782 - 789.
328. Goebel W, Lieb WE, Ho AC, Sergott RC, Farhouman R, Grehn F. Color Doppler imaging: a new technique to assess orbital blood flow in patients with diabetic retinopathy. Invest Ophthalmol & Visual Science 1995; 36: 864 - 870.
329. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho AC, Orlock D. Indocyanine green video angiography of central serous choroidopathy. Arch Ophthalmol 1994; 112: 1057 –
330. Moadel K, Yannuzzi LA, Ho AC, Ursekar A. Retinal vascular occlusive disease in a child with neurofibromatosis. Arch Ophthalmol 1994; 112: 1021 - 3.
331. Yannuzzi LA, Hope-Ross M, Slakter JS, Guyer DR, Sorenson JA, Ho AC, Sperber DE, Freund KB, Orlock D. Analysis of vascularized pigment epithelial detachment using indocyanine green video angiography. Retina 1994; 14: 99 -113.
332. Ho AC, Sergott RC, Regillo CD, Savino PJ, Lieb WE, Flaharty PM, Bosley TM. Color Doppler hemodynamics of giant cell arteritis. Arch Ophthalmol 1994; 112: 938-945.
333. Sorenson JA, Yannuzzi LA, Slakter JS, Guyer DR, Ho AC, Orlock D. A pilot study of digital indocyanine green video angiography for recurrent choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 1994; 112: 473-9.
334. Ho AC, Fisher YL, Slakter JS, Guyer DR, Sorenson JA, Yannuzzi LA. Intraoperative real-time indocyanine green video angiography in subretinal surgery. Arch Ophthalmol 1994; 112: 872-874.Slakter JS, Yannuzzi LA, Sorenson JA, Guyer DR, Ho AC, Orlock D. A pilot study of digital indocyanine green video angiography-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 1994; 112: 465-72.
335. Ho AC, Yannuzzi LA, Guyer DR, Sorenson JA, Slakter JA, Orlock DA. Intraretinal accumulation of indocyanine green dye in age-related macular degeneration. Ophthalmology 1994; 101: 534-541.
336. Regillo CD, Sergott RC, Ho AC, Belmont JB, Fisher DH. Hemodynamic alterations in the acute retinal necrosis syndrome. Ophthalmology 1993; 100: 1171-6.
337. Ho AC and Rapuano CJ. Pasteurella multocida keratitis and corneal laceration by cat scratch. Ophthal Surg 1993; 24: 346-348.
338. Ho AC, Guyer DR, Yannuzzi LA, Brown GC. Ocular syphilis: Classic manifestations and recent observations. Sem in Ophthalmol 1993; 8: 53-60.
339. Sergott RC, Flaharty PM, Lieb WE, Ho AC, Kay MD, Mittra RA, Savino PJ, Bosley TM. Color Doppler imaging identifies four syndromes of the retrobulbar circulation in patients with amaurosis fugax and central retinal artery occlusions. Trans Am Ophth Soc 1992; 90: 383-398.
340. Ho AC, Lieb WE, Flaharty PM, Brown GC, Bosley TM, Savino PJ, Sergott RC. Color Doppler imaging of the ocular ischemic syndrome. Ophthalmology 1992; 99: 1453-1462.
341. Lieb WE, Flaharty PM, Ho AC, Sergott RC. Color Doppler imaging of the eye and orbit: A synopsis of a 400 case experience. ACTA Ophthalmol 1992; 204: 50-54.

Non Peer-Reviewed Original Books, Reviews, Chapters and Other Publications (partial list)
1. Cohen MN, Fineman MS, Ho AC, editors. Retina. Wolters Kluwer Health; 2025.
2. Bommakanti N, Sivalingam M, Deaner J, Yonekawa Y, Mehta S, Ho AC. A strong fellowship finish. Retina Today. 2025 March: 14-15
3. Avery RL, Ho AC. Tenacity pays off. Retina Today. 2024 November/ December: 5
4. Hepp R, Avery RL, Ho AC. Geographic Atrophy Therapies to Watch, An update on complement inhibitors, gene and cell therapies, and novel approaches. Retina Today. 2024 November/ December: 34-36
5. Ho AC, Avery RL. Problem solvers unite. Retina Today. 2024 October: 8
6. Ho AC, Avery RL. Perseverance is key. Retina Today. 2024 September: 5
7. August AH, Shields CN, Pendyala J, Humayun A, Williamson JE, DeSimone JD, Duffner E, hamdan AS, Keil JM, Ho AC. Diabetes Day: Improving Access to DR Care, An annual free screening event in Philadelphia has improved patient access and reduced preventable diabetic vision loss. Retina Today. 2024 September: 18-20
8. Mandava NK, Kuriyan AE, Ho AC, Hsu J, Regillo CD, Klufas MA. Enhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema. Curr Opin Ophthalmol. 2024 May 1;35(3):197-204.
9. Starr MR, Chen E, Ho AC, Guyer DR. Angioid Streaks. InAlbert and Jakobiec's Principles and Practice of Ophthalmology 2022 Apr 23 (pp. 3663-3677). Cham: Springer International Publishing.
10. Tibbetts MD, Ho AC. Hemoglobinopathies. Ophthalmology. 5^th ed. Yanoff M, Duker J et al (editors), Mosby London, 2018.
11. Ghodasra DH, Ho AC, Jayasundera KT, Zacks DN. Retinal Prostheses: Clinical Outcomes and Potential Complications. In: Retinal Prosthesis. Essentials in Ophthalmology. Springer, Cham; 2018:77-90.
12. Ho AC. Why timing is everything in AMD: surgeons’ goal should be maintaining functional vision in a higher proportion of patients. Ophthalmology Times. 2018;43(12):4,14,17-18.
13. Ho AC. Optimizing Visual Outcomes in Patients with Neovascular AMD Through Early Detection. Ophthalmology Management. March 2018.
14. Shahlaee A, Regillo CD, Ho AC. 8 Optical Coherence Tomography Angiography and Arterial Occlusions. OCT Angiography. November 2017.
15. Samara WA, Regillo CD, Ho AC. 10 Optical Coherence Tomography Angiography and Central Serous Chorioretinopathy. OCT Angiography. November 2017
16. Adam MK, Ho AC. The Pros and Cons of Heads-up Surgery. Review of Ophthalmology. September 2017:53-55
17. Pitcher AD, Ho AC. The Ophthalmologist’s Role in Caring for Patients With Diabetes. Cataract & Refractive Surgery Today. March 2016:19-22
18. Ho AC. The Future of Long-Term AMD Treatment: Could a novel drug-delivery platform be a new standard of care? Cataract & Refractive Surgery Today. February 2016:36-39
19. Ho AC, Friess DW, Hsu J, Rahimy E. The Case for 3-D Retina Surgery. Retina Today. December 2015:76-78
20. Ho AC. Safety, reliability and benefits of the Argus II prosthesis system. Ophthalmology Times. Oct 2015;11(8):40-43
21. Ho AC. Early Detection of Choroidal Neovascularization Using Home Monitoring. Retina Today. May/June 2015:66-68
22. Ho AC, Puliafito CA. Eight Questions With Dr. Puliafito. Ophthalmic Surgery, Lasers and Imaging Retina. 2015 Jan 1;46(1):145-7.
23. Hsu J, Mehta S, Ho AC. Surgical Management of Proliferative Diabetic Retinopathy (Chapter) Management of Complicated Vitreoretinal Diseases, pp.79-88
24. Anderson E, Duker JS, Ho AC, Kitchens JW. Evolving Issues in Diabetic Vascular Complications: Understanding Ocular Manifestations. Retina Today CME. Original release date Feb 1 2016, Expiration Date Feb 1, 2017.
25. Ho AC, Ober MD, Sadda SVR, Singh RP. Current Insight Into Retinal Disease Management: Focus on DME and Intravitreal Corticosteroids. Retina Today CME. Original release date Mar 1 2015, Expiration Date Mar 1, 2016.
26. Ho AC, Avery RL, Brown DM, Slakter JS. Individualizing Therapy for Patients with Neovascular AMD and DME: Considerations for Short- and Long-Term Management. Regeneron CME Monograph. Original release date April 1, 2014, Expiration date April 30, 2015.
27. Kaiser PK, Duker JS, Ho AC, Martin DF. Clinical Trial Updates-Putting Research into Practice for Retinal Diseases. Regeneron Pharmaceuticals CME Monograph. Original release date May 2014, Expiration Date May 31, 2015.
28. Ho AC. “Woman Gets Life-Changing Bionic Eye Implant”. New York Daily News by Meredith Engel, September 16, 2014. http://www.nydailynews.com/life-style/health/woman-life-changing-bionic-eye-implant-article-1.1941439
29. Ho AC, Avery RL. Scanning the Horizon of Treatments for DME. Retina Today April 2014, page 7.
30. A Chiang, AJ Witkin, CD Regillo, AC Ho. Fundus Imaging of Age-Related Macular Degeneration. Age Related Macular Degeneration Diagnosis and Treatment 2011, 39-64, DOI:1-.1007/978-1-4614-0125-4_4.
31. Tibbetts MD, Ho AC. Vascular Disorders: Hemoglobinopathies. Figure 21-6(a) Widefield angiography of PSR.jpg; Figure 21-6 (b) higher magnification fluorescein angiography of PSR.jpg. 4e Ch 6.23.
32. Ho AC and Regillo CD. Age-related Macular Degeneration Diagnosis and Treatment. Springer, New York 2011.
33. AC Ho, S Gray, A Rundle, Z Li, W Yee Murashashi. Ranibizumab in Patients With Macular Edema Following Retinal Vein Occlusion: 12-Month Outcomes of BRAVO and CRUISE. Program and abstracts of the Association of Research in Vision and Ophthalmology . ARVO 2010 Annual Meeting. Invest Ophthalmol Vis Sci 2010.
34. Ho AC, Wolfe J. Macular Hole, Chapter 21 Retina Section Volume 3. Duane’s Clinical Ophthalmology. 2009
35. Ho AC. KOL Corner 3-pseudophakic RD. Retina Times. 2008
36. Ho AC. Anti VEGF for AMD. August 2008. Diabetic Eye Disease OTA.
37. Packo KH, Murray TG, Ho AC, Pollack, JS, Rizzo S, Dugel, PU. Exploring the Utility of Next-generation Vitrectomy Systems. Round table discussion November 2008.
38. Ho AC. Reply to letter by Riemann, et al regarding 25 gauge vitrectomy with silicone oil tamponade. Retina 2008.
39. Ho AC. Navigating AMD Treatment Option: Practical Answers to Complex Questions. Neovascular Age-Related Macular Degeneration: Updating the Treatment Paradigm. Advanced Studies in Ophthalmology. Johns Hopkins Medicine. 2007: 33-37.
40. Fintak DR and Ho AC. Perioperative and Operative Considerations in Diabetics. Ophthalmol Clin N Am 2006: 427 – 434.
41. Bressler N, Heier J, Ho AC, Williams G. Clinical Advances in AMD 2006 Update. Managing Patients’ and Physicians’ Expectations in the Treatment of AMD. Johns Hopkins CME Press, 2006.
42. Ho AC. Safe and Brighter Endoillumination for Vitrectomy Surgery. Retina Times, 2005.
43. Charles S, Ho AC, Packo K, Regillo CD. 25 Gauge Vitrectomy Roundtable Discussion. Ophthalmology Times 2005.
44. Schachat A, D’Amico D, Gragoudas E, Ho AC, Regillo CD, Rosenfeld P. Age-Related Macular Degeneration Prevention and Therapy. Johns Hopkins CME Press 2005.
45. Kaiser R and Ho AC. Review of Ocular Angiogenesis and New Therapies for Choroidal Neovascularization. Ophthalmology Times 2005.
46. Ho AC. Anecortave Acetate: Treatment for Age-Related Macular Degeneration. Retinal Physician, 2005.
47. Ho AC, Johnson M, Saperstein D, Williams G. Treating Neovascular Age-Related Macular Degeneration: An Evidence-Based Guide to Therapy by Lesion Type. Ophthalmology Times, 2005.
48. Ho AC. Complication of Botox Injection: Subretinal Botox Injection. Dermatology News, 2005.
49. Duker J and Ho AC. Saving the Eyesight of Diabetic Patients Begins at Diagnosis. Endocrine Today, 2005.
50. Puliafito C, Ho AC, Slakter J, Rosenfeld P. New Perspectives on Age-Related Macular Degeneration. Ocular Surgery News, 2005.
51. Ho AC. Prevention Therapies for Age-Related Macular Degeneration. Letter to the Editor. Primary Care Optometry News, 2004.
52. Ho AC. Prevention Strategies for Age-Related Macular Degeneration: New Perspectives. Ocular Surgery News, 2004.
53. Ho AC. Age-Related Macular Degeneration: Current and Emerging Treatments. Foresight 2003: 1, 1 – 11.
54. Ho AC. Retsumer Report: Vitrectomy Machines/Systems. Retina Times, American Society of Retina Specialists, 2003; 22-25.
55. Garg S, Ho AC. Retinal Arterial Obstructive Disease. Atlas of Posterior Segment Imaging. Kaiser P (editor) Elsevier, Philadelphia 2003.
56. Ho AC. Hemoglobinopathies. Ophthalmology. Yanoff M, Duker J et al (editors), Mosby, London 2003.
57. Ho AC, Brown GC, McNamara JA, Recchia FM, Regillo CR, Vander JF. Retina. Color Atlas and Synopsis of Clinical Ophthalmol ogy. McGraw Hill, New York 2003.
58. Stein J, Brown GC, Ho AC. Fluorescein Angiography for Retinal Vascular Diseases. Tasman W and Jaeger E (editors) Duane’s Foundations of Clinical Ophthalmology, Lippincott Williams Wilkens, Philadelphia 2002.
59. Ho AC and Lee HC. Macular Hole. Tasman W and Jaeger E (editors) Duane’s Clinical Ophthalmology, Lippincott Williams Wilkens, Philadelphia 2002.
60. McCabe F and Ho AC. Argon Laser to Drusen. Lim J (editor) Age-Related Macular Degeneration. Marcel Drekker, 2002.
61. McCabe F, Ho AC. Vein Occlusion: Current and Future Therapies. Review of Ophthalmology 12: 2001.
62. Ho AC. "How to Use the Instruments For Examination of the Posterior Segment". Clinical Pathways in Vitreoretinal Disease, Steidl S and Hartnett M eds., Thieme Publishers, New York 2001.
63. Shuler MF, Borillo L, Ho AC. Photodynamic Therapy for Age-Related Macular Degeneration. Current Opinion in Ophthalmology 2001.
64. Ho AC. "A Preliminary Study of Photodynamic Therapy Using Verteporfin for Choroidal Neovascularization in Pathologic Myopia, Ocular Histoplasmosis Syndrome, Angioid Streaks and Idiopathic Causes". (review) Evidence Based Eye Care 2000.
65. Connolly BP, Ho AC. Essentials of the funduscopic examination. Clinics Atlas of Office Procedures , Maus M, Jeffers J, Holleran E eds., WB Saunders Philadelphia, 2000.
66. Sung J, Ho AC. Macular Pucker. Tasman W (editor) Spaeth’s Ophthalmic Surgery, 4th edition, 2000.
67. Ho AC. Macular Hole. Tasman W (editor) Spaeth’s Ophthalmic Surgery, 4th edition, 2000.
68. Ho AC. Ocular Toxoplasmosis (review). Evidence Based Eye Care 2000.
69. Ho AC. New and Investigational Therapies for Age-Related Macular Degeneration. The Panretinal View. Ophthalmology Times 1999.
70. Ho AC. Laser Treatment of Eyes with Drusen in Current Concepts in Ophthalmology by GC Brown, (editor) 1999.
71. Ho AC. Miscellaneous Macular Diseases. Brown GC, Flynn HW, and Regillo CD, (editors). Essentials of Vitreoretinal Disease. Thieme, London. 1998.
72. Ho AC. Hemoglobinopathies, in Ophthalmology. Yanoff M, Duker J et al (editors), Mosby, London 1998.
73. Ho AC, Guyer DR, Fine SL. Clinical Examination of the Posterior Segment of the Eye, in Vitreous - Retina - Macula. Guyer DR, Yannuzzi LA, Chang S, Shields J, Green WR. (editors), WB Saunders, Philadelphia 1998.
74. Ho AC. Macular Hole, in Vitreous - Retina - Macula, Guyer DR, Yannuzzi LA, Chang S, Shields J, Green WR (editors) WB Saunders, Philadelphia 1998.
75. Ho AC. Wills Eye Hospital Atlas of Clinical Ophthalmology. Tasman, WS and Jaeger EA (editors) and Atlas of Clinical Ophthalmology. Albert, DM and Jakobiec FA (editors). (Review) Ophthalmic Surgery and Lasers 1998; 29: 167 - 168.
76. Ho AC. Age-Related Macular Degeneration. Current Concepts in Ophthalmology 1998; 5: 44 - 48.
77. Ho AC. Indocyanine Green Dye Imaging of the Retina and Retinal Vascular Diseases. (Chapter) in Yannuzzi LA (ed) Indocyanine Green Videoangiography. CV Mosby, St Louis 1997.
78. Ho AC. Clinical Decisions in Medical Retinal Diseases. Tasman, WS (editor) (Review) Ophthalmic Surgery and Lasers 1996; 27: 158 - 159.
79. Ho AC. Age-related macular degeneration: Where are we and where do we need to go? Review of Ophthalmology 1995; 2: 55 - 67.
80. Ho AC. Clinical Retinopathies. Dodson PM, Gibson JM, and Kritzinger EE. Ophthalmic Surgery and Lasers 1995; 26: 584.
81. Ho AC and Guyer DR. Subfoveal choroidal neovascularization and indocyanine green dye-enhanced laser photocoagulation. In: Benson WE, Coscas G, Katz LJ Current Techniques in Ophthalmic Laser Surgery 1995; Current Medicine, Philadelphia.
82. Ho AC. Wills Eye Hospital Office and Emergency Room Treatment of Eye Disease. Second Edition. Retina Section Contributing author. JB Lippincott, Philadelphia 1994.

Allen C. Ho, MD

Awards & Honors

Peer-Reviewed Publications

Non Peer-Reviewed Publications (partial list):